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ABSTRACT
Dysfunction in homeostatic mechanisms of cell death and 
proliferation are considered to be important in carcinogenesis. The 
p53 gene has been implicated in the regulation of cell death and 
proliferation. The host response was measured through sequential 
immunohistochemical (IHC) detection of apoptosis, PCNA, and p53 in 
livers of Fundulus grandis fish exposed to MNNG or to 2-AF, two known 
carcinogens. Studies performed determined the stability of MNNG in 
saltwater, the suitability of different fixatives on IHC detection of 
apoptosis, PCNA-PC10, and p53 (various clones), and frequencies of 
expression of apoptosis, PCNA, and p53. A total of 996 fish specimens 
were utilized.
Results indicated that 34 |iM MNNG saltwater solution degraded 
into its components 70 minutes after its preparation. Preservation of 
tissue morphology and application of mammalian methodologies for 
immunohistochemical detection of apoptosis, PCNA-PC10, and p53-PAb240 
were best accomplished by buffered 10 % formalin solution.
Significant differences were found in the levels of p53 protein 
detected at experimental day 180 between the MNNG exposed and the 
control fish groups. Experimental data suggested that apoptosis in 
fish livers is significantly suppressed at experimental day 180 as a 
result of exposure to MNNG and possibly to 2-AF. Detection of PCNA in 
liver cells was significantly increased by day 9 of the experiment as 
a result of chemically-mediated cell injury regardless of the compound 
used. Concurrent use of a marker for cell death, such as apoptosis, 
with one for proliferation greatly enhances the assessment of the 
effect of these compounds on liver cell response. Increased detection 
of p53, suppression of apoptosis, increased cellular proliferation, 
and increased occurrence of putative preneoplastic changes noted 
histologically (basophilic foci, megalocytosis, and karyomegaly) in
vii
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the liver of fish subjected to MNNG suggest that tumors with mutated 
p53 gene would develop, in time, in liver. Because similar 
histological changes were noted in the 2-AF exposed fish group in the 
absence of increased p53, it is hypothesized that the neoplastic 
process which may occur as a result of exposure to this compound may 
not initially involve mutation of the p53 gene, but that other 
mechanisms of carcinogenesis may be involved.
viii
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INTRODUCTION
In multicellular organisms homeostasis is maintained through a 
balance between cell proliferation and cell death. Dysfunction in the 
maintenance of this balance is believed to be important in the 
pathogenesis of neoplasia. This makes the study of cell death, such 
as apoptosis, an active area of research in today's multidisciplinary 
biological sciences. Apoptosis is now accepted as a critical element 
in the repertoire of cellular responses, but there is still an 
incomplete picture of the multiple features and complex intracellular 
processes involved. The assessment of cell proliferation has also 
become a common monitor of homeostatic host response to cell injury. 
Concurrent use of a marker for cell death, such as apoptosis, with one 
for proliferation greatly enhances the assessment of injurious agents 
on host cellular response. The p53 gene has been implicated directly 
and indirectly in the regulation of cell death and proliferation. The 
normal (wild type) p53 gene protein suppresses the division of 
genetically damaged or altered cells by causing a pause in the cell 
cycle and by promoting exit from it through apoptosis (Sidransky and 
Hollstein 1996). Damage to the cellular DNA can result in either 
restoration of its genomic integrity, or in activation of the cell's 
own suicide mechanism, apoptosis, resulting in the elimination of the 
affected cell from the rest of the population. This function of p53 
as "guardian of the genome" may extend to a role in initial monitoring 
and repair of DNA damage in addition to direct control of cell growth 
and death (Lane 1992) .
In this study the host response was measured through sequential 
immunohistochemical detection of apoptosis, proliferating cell nuclear 
antigen (PCNA), and p53 in livers and liver lesions of Fundulus 
grandis fish exposed to the alkylating agent, n-methyl-n’-nitro-n- 
nitrosoguanidine (MNNG), or to the polycyclic aromatic hydrocarbon, 2- 
aminofluorene (2-AF).
1
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The first chapter covers an extensive review of the current 
literature on apoptosis, including appropriate reviews on cell 
proliferation and on p53 gene as these relate to the process of 
apoptosis. The review is centered primarily on the molecular aspects 
of the control of apoptosis.
The second chapter explains the experimental design and discuss 
preliminary work required to perfect the methodology for subsequent 
experiments; these include studies on MNNG stability on saltwater, 
development and application of an in-situ DNA labeling technique for 
detection of apoptosis in fish, and evaluation of different fixatives 
on immunohistochemical detection of apoptosis. This is followed by an 
experiment on the comparative immunohistochemical detection of 
apoptosis and related histological changes in the liver of Fundulus 
grandis exposed to MNNG and 2-AF compared to unexposed fish at 
different time intervals. The chapter finalizes with sections on 
results and discussion.
The third chapter describes primarily applications of a 
mammalian technique for immunolocalization of proliferating cell 
nuclear antigen (PCNA) protein in fish, preceded by a brief 
description of the experimental design and pertinent preliminary work 
needed, as discussed in chapter 2. Experiments on the comparative 
liver tissue response to MNNG and 2-AF exposure compared to control 
fish through sequential evaluation of both immunolocalization of PCNA 
and histological changes will be discussed. The chapter will end with 
sections on results and discussion.
The fourth chapter describes experiments on the comparative 
immunohistochemical detection of the p53 protein in the liver of 
Fundulus grandis exposed to MNNG and 2-AF compared to unexposed fish. 
As in the previous chapters, brief descriptions on experimental design 
and pertinent preliminary work are included. The effect of different
2
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fixatives on immunohistochemical detection of p53 protein using 
various commercially available p53 antibody clones on were evaluated 
initially. This was followed by application of the results obtained 
in the preliminary experiments, and the sections on results and 
discussion.
The final chapter contains the overall conclusions and outcomes
about this work. Appendixes are included at the end of the
manuscript, before the Vita, and include data and statistical tables.
Philosophy of using aquatic organisms as test species for human health 
risk assessment
In the past few years fish have become popular models for the 
study of carcinogenesis. The philosophy of using aquatic organisms as 
test species for human health risk assessment rests on several factors 
(Huff 1995). These include the public awareness that the water used 
for drinking, recreational and commercial use, and fishing may contain 
significant amounts of toxic and carcinogenic compounds, and that the 
consumption of aquatic organisms living in contaminated waters could 
pose serious health hazards. Human concern centers on whether eating 
fish and other sea creatures contaminated with chemicals causes or 
exacerbates toxic, reproductive, and long-term adverse effects such as 
cancer. It follows also that fish are natural sentinels of aquatic 
pollution and that use of fish as an alternative species for 
experimental carcinogenesis studies has sound scientific basis. The
use of fish in this manner has several advantages and disadvantages. 
Advantages include: 1) the low cost per animal, which permits 
statistically challenging, large-scale studies; 2) small body size at 
exposure times allows studies with several different chemicals at one 
time; 3) its nonmammalian status strengthens the comparative aspects 
of different mechanisms of chemically-induced cell injury and 
carcinogenesis for extrapolation of animal studies to humans; 4) the
availability of externalized embryos in large numbers provides for a
3
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practical approach in carcinogenesis, teratogenesis, and gene transfer 
studies; 5) totally homozygous clones may be created and propagated 
relatively easily; 6) a similar overall biochemical and molecular 
basis of carcinogenesis (i. e., xenobiotic metabolism pathways, proto­
oncogene activation, and histological progression) exists between fish 
and mammals; and 7) direct contact of fish with environmentally 
sensitive marine and fresh water habitats makes them a more suitable 
sentinel for assessment of potential carcinogenic and/or toxicologic 
hazardous conditions. Disadvantages include: 1) absence of certain 
target organs in fish, such as colon, rectum, breasts, prostate, and 
others; 2) the long generation time of some species (trout for 
example) may hinder and limit genetic studies; 3) unavailability of 
nutritional and husbandry requirements for local, ecologically 
sensitive species (Fundulus grandis, for example) could hinder its 
potential as a laboratory-raised species; 4) the lack of current 
knowledge of the role of the immune or endocrine systems on regulation 
and control of cancer; 5) the relative availability of only a few, 
well characterized fish cell lines suitable for transformation 
studies, gene sequencing, and chromosomal mapping; and 6) the 
relatively low number of different test species used today for 
carcinogenesis studies.
A main legal, ethical, and scientific concern in using 
alternative test species, like fish or even rats and mice, is the 
direct extrapolation of the data obtained from these organisms to 
humans. Could it be ultimately predicted that humans are at increased 
risk from eating fish from contaminated waters? Probably not. We 
could gain substantially more by unraveling the processes of 
chemically-induced cell injury and the host's subsequent cell and 
tissue response. Public health logic and human safety priorities will 
ultimately dictate the reliance on the use of aquatic species for the 
study of cancer.
4
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If the field of toxicologic pathology is moving increasingly 
toward the use of molecular markers, one could ask in terms of 
classical pathology methods what is to be gained by the use of 
molecular biomarkers and what is to be lost by abandoning such 
classical techniques? Such a question strikes straight at today's 
quandary about the involvement, or the lack thereof, of pathologists' 
participation in molecular pathology.
For the most part, diagnosis and classification of cell injury 
is based on a combination of clinical, macroscopic, and microscopic 
features. This is true for humans and animals, including fish. 
Descriptions and diagnosis of chemically-mediated cell injury as well 
as of certain other types of cell injury, are frequently subjective 
and semiquantitative at best. Efforts to develop special 
instrumentation along with new biotechnology products, which allow the 
application of many molecular and immunohistochemical techniques, have 
widened our appreciation and understanding of those events that occur 
in an injured cell. This has expanded the view and interpretation of 
disease to the extent that a better, more informative, less 
subjective, and more quantitative assessment can be made about 
chemically-mediated cell injury. Pathologists will make substantial 
gain by combining molecular biomarkers with the more classic 
histologic techniques. Replacement of one technique by the other 
would pose a great danger for the discipline, as replacement of the 
pathologist by the molecular biologist could become the norm rather 
than the exception. The use of molecular biology techniques in 
pathology are here to stay, whether we are ready or not.
What is Pathology anyway?
Pathology studies the derangement of molecules, cells, tissues, 
and function that occur in living organisms in response to injurious 
agents or deprivations. Injurious agents may include chemical 
compounds, forms of energy, injurious substances and deprivation of
5
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essential nutrients. Genetic factors can also be considered as 
potential injurious agents (Jones, Hunt et al. 1997).
The key word is response, which consists of a spectrum of reactions 
ranging from reversible injury, to irreversible injury and death, to 
malignant transformation. When the response impairs the health and/or 
well-being of an individual, it is then regarded as disease.
The body is also subjected to many normal stimuli to which it 
responds in a similar manner as it does to abnormal or deleterious 
stimuli. For example, the atrophy and necrosis found in thymic 
involution is similar to the atrophy and necrosis noted in an organ or 
tissue after impairment of its blood supply. Tissue (or cell) death 
caused by anoxia may be passive or active (as in inflammation). Most 
cases represent life saving defense mechanisms, that may be efficient 
(leading to no disease) or inefficient (leading to disease). 
"Pathologists must be able to recognize that all such reactions are 
real, consistent, and recognizable, and must be aware of both the 
benefits and disadvantages of these reactions in the host" (Jones,
Hunt et al. 1997) .
About cell injury, cell death, and necrosis
Cell injury refers to any biochemical or structural alteration 
that impairs the ability of a cell to function normally. Such injury 
may be mild, transient, and reversible, or it may of such severity 
that it becomes irreversible.
Cell death refers to that point when cell injury becomes 
irreversible, or has passed the "point of no return". Cell death 
occurs in two biochemical and morphologically distinct ways: 
accidental or "unscheduled" cell death (formerly known simply as 
necrosis) and apoptosis (Majno and Joris 1995; Jones, Hunt et al.
1997).
Necrosis refers to the characteristic light microscopic changes 
that result from enzymatic degradation of the nucleus and cytoplasm
6
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that define cell death, whether through accidental cell death or 
through apoptosis. The typical morphologic changes of necrosis are 
not usually seen for 12 to 18 hours after death of the cell. Hence, 
there is a period of time when a "dead" cell appears microscopically 
identical to a "living" cell. Hopefully, these statements help to 
clarify the confusion that exists in today's literature that is still 
trying to differentiate between apoptosis and necrosis as different 
forms of cell death. For an even "bigger" confusion see the paper of 
Columbano, 1995 (Columbano 1995).
The causes of cell injury and death are several. These include: 
1) forms of kinetic injury (including mechanical, thermal, and 
radiation); 2) exposure to reactive forms of exogenous chemicals (such 
as poisonous plants and microbiologic origin) and exogenous chemicals 
(such as toxic products of metabolism, peroxidases, and free 
radicals); 3) deprivation of essential nutrients (like water, oxygen, 
and foodstuffs); 4) immunologic reactions; and 5) genetic diseases.
Accidental cell death is the most commonly recognized type, and, 
although it has numerous causes, it is typified by biochemical and 
morphologic alterations resulting from anoxia (ischemia). The term 
oncosis has been used to describe the morphological appearance of 
ischemic cell death (Majno and Joris 1995). Apoptosis, which is often 
referred to as "programmed cell death", often results from activation 
and transcription of specific genes present in all cells. In some 
situations, activation of these genes occurs normally, accounting for 
the normal turnover of cells in the body. Examples of these 
situations are found during normal embryologic development of limbs, 
thymus, or brain, where certain cells are predetermined or programmed 
to die at certain times while others continue to proliferate and 
differentiate. Under certain pathologic conditions, however, these 
genes can be activated prematurely or triggered in cells where they 
are normally suppressed leading to premature atrophy or senescence of
7
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the affected organs or tissues. Examples of this phenomenon are noted 
in thymic atrophy, experimentally induced by corticosteroids and 
radiation; tumor necrosis factor alpha (TNF-a)-induced cachexia; in 
the lymphoid depletion that occurs in human, simian, feline, and 
probably bovine immunodeficiency syndromes; and in the elimination of 
foreign or virally infected cells, when such death is mediated by 
cytotoxic T-lymphocytes.
Unlike accidental cell death, where large numbers of diversified 
cells in a tissue or organ are often affected, apoptosis tends to 
affect individual or small clusters of cells of a specific type. This 
suggests that different cells may vary in their threshold level for 
apoptosis to occur.
Although often referred to as genetically mediated or programmed 
cell death, the cytoplasmic changes that characterize apoptosis have 
been induced in cells from which the nuclei has been removed 
experimentally; this suggests that transcription of genes and 
synthesis of their protein products are not essential for induction of 
apoptosis under most situations.
The proteins involved are constitutively expressed in mammalian 
cells, but are normally rendered inactive by "antiapoptotic" proteins, 
synthesized by the same cell, possibly in response to the so-called 
survival signal received from neighboring cells, extracellular 
substrates, or fluids. The survival signals include growth factors, 
extracellular matrix components, and various hormones. Loss of these 
factors spontaneously initiates apoptosis.
Apoptosis may be physiologic and represent a mechanism by which 
a balance between cell growth (proliferation) and cell death is 
maintained. On the other hand, apoptosis may be regarded at times as 
pathologic or deleterious to the host, especially when this delicate 
balance between growth and death is disturbed. Inhibition of
8
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apoptosis may be as important as amplified oncogene expression in the 
pathogenesis of certain neoplastic diseases.
Although apoptosis may be initiated by many different intrinsic 
and extrinsic signals, all of these signal pathways converge at some 
point to activate a common, genetically controlled mechanism of cell 
death. The genes and gene-products responsible for this apoptotic 
mechanism are thought to be present in all cells. Regulation of their 
expression is tightly controlled by other genes. Mammalian examples 
of these regulatory genes lie in the bcl-2 gene family, while related 
genes have been found in the fruit fly, Drosophila melanogaster, and 
in the nematode, Caenorhabditis elegans. Of vital biological 
importance is their conservation among such a wide range of phylogenic 
species.
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CHAPTER 1. LITERATURE REVIEW ON APOPTOSIS
Introduction
The importance of the process known as apoptosis has been widely 
recognized over the past few years and its significance in the field 
of biology is still being evaluated today. Apoptosis is now accepted 
as a critical element in the repertoire of cellular responses, but 
there is still an incomplete picture of the multiple features and 
complex intracellular processes involved. This makes the study of 
apoptosis an active area of research in today's multidisciplinary 
biological sciences, including the field of veterinary pathology.
Many articles have been published in recent years reviewing the 
process of apoptosis (Columbano 1995; Liebermann, Hoffman et al. 1995; 
Majno and Joris 1995; Moller 1995; Payne, Bernstein et al. 1995; 
Steller 1995; Lee and Bernstein 1995a; Bosman, Visser et al. 1996; 
Chiarugi and Ruggiero 1996; Denmeade, Lin et al. 1996; Hale, Smith et 
al. 1996; McConkey, Zhivotovsky et al. 1996; Pritchard and Watson 
1996; Wu 1996; Dixon, Soriano et al. 1997; Fleisher 1997; Rowan and 
Fisher 1997).
Dysfunction of apoptotic mechanisms are probably responsible for 
oncogenesis, autoimmunity, and degenerative diseases as reviewed by 
several recently published articles (Bursch, Oberhammer et al. 1992; 
Carson and Ribeiro 1993; Thompsom 1995; Bosman, Visser et al. 1996; 
Duke, Ojcius et al. 1996; Mallat, Tedgui et al. 1996; Shimushi, Masuda 
et al. 1996) .
In multicellular organisms homeostasis is maintained through a 
balance between cell proliferation and cell death. Much is known 
about the control of cell proliferation; however, less is known about 
the control of cell death. Cell death during embryogenesis, 
metamorphosis, endocrine-dependent tissue atrophy, and normal or 
physiologic tissue turn over occurs primarily through an 
evolutionarily conserved form of cell suicide called apoptosis.
10
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Apoptosis is a Greek word that means "leaves dropping off here and 
there from a tree". The prefix "apo" means "from" and "ptosis" means 
"a fall".
Programmed cell death was discussed as a physiological event as 
soon as stains became available. It was introduced in an 1885 paper 
by the same Walter Flemming who created the terms chromatin and 
mitosis (Flemming 1885); Flemming studied ovarian follicles in mammals 
and noticed that the epithelial lining of regressing follicles was 
littered with cells, the nuclei of which were breaking up; Flemming 
described the half-moons of pyknotic chromatin typical of apoptosis as 
well as apoptotic bodies loose in the cavity of the follicle, and 
called it chromatolysis, referring to the fact that the nucleus 
ultimately disappears. A few months later, a german medical student, 
Franz Nissen, (Nissen 1886) published a paper describing similar 
observations in the mammary gland. In 1914, a german anatomist,
Ludwig Graper, published a paper entitled: "A new point of view
regarding the elimination of cells” (Graper 1914), where it was 
established that some mechanism must exist to counterbalance mitosis; 
he concluded that Flemming's chromatolysis was the answer. But his 
paper had no significant impact; it was overlooked, perhaps because it 
appeared right at the outset of WW1 in a German journal on cellular 
investigation that many pathologists might have missed.
In 1971 Kerr (Kerr 1971) described shrinkage necrosis in an 
induced liver atrophy experiment. A year later, Kerr called it 
apoptosis (Kerr, Wyllie et al. 1972).
Between 1976 and 1981, three groups examined chromatin from 
irradiated tissues electrophoretically and found that it broke down 
into fragments with ladder-like pattern (Skalka, Matyasova et al.
1976; Yamada, Ohyama et al. 1981; Zhivotovsky, Zvonareva et al. 1981).
11
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In 1984 Wyllie et al. linked this phenomenon to apoptosis(Wyllie, 
Morris et al. 1984).
The morphologic and biochemical features of apoptosis have been 
reviewed in textbooks of pathology and recent articles(Majno and Joris 
1995; Jones, Hunt et al. 1997). Apoptosis is a form of cell death 
characterized by morphological as well as biochemical criteria, and it 
can be considered as a counterpart of mitosis. Cell shrinkage 
characterizes apoptosis in contrast to the cell swelling (cytoplasm 
and organelles) that occurs in hypoxic cell death. The Na-K pump 
remains unaffected initially, and the membranes remain intact. 
Activation of cellular proteases lead to disruption of cytoskeletal 
elements and causes the cell to shrink. Activation of endonucleases 
occurs early in apoptosis; this leads to DNA cleavage between 
nucleosomes giving rise to fragments of 180-200 base pairs, agarose 
gel migration of which leaves a characteristic ladder pattern; this is 
in contrast with the heterogeneous agarose gel migration pattern left 
by the DNA from cells which have died as a consequence of 
hypoxia/anoxia.
The nuclear chromatin becomes electrodense, and often assumes a 
characteristic "half-moon" configuration beneath the undisrupted 
nuclear membrane. The nuclei may break up into dense, membrane bound 
masses, in contrast to the karyorrhexis seen in accidental cell death 
(Jones, Hunt et al. 1997) or in oncosis (Majno and Joris 1995), in 
which the nuclear membrane is disrupted. During the shrinkage 
process, the cytoplasmic plasma membrane emits small pseudopodia 
(buds), rather than the cytoplasmic blebs noted in hypoxic cell death. 
These pinch off from the shrunken remains of the apoptotic cell, 
giving rise to apoptotic bodies, which are membrane-bound bodies that 
may contain several cellular organelles including mitochondria, 
lysosomes, golgi, endoplasmic reticulum, and masses of condensed 
chromatin surrounded by a nuclear membrane.
12
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A perceptible inflammatory reaction is not elicited by these 
apoptotic bodies since no leakage of the usual mediators found in an 
inflammatory process occurs. Scavenger macrophages and/ or 
neighboring cells ingest and degrade these apoptotic bodies.
The process is under genetic control (Kerr, Winterford et al. 
1994; Wyllie 1994) and can be initiated by an internal clock, or by 
extracellular agents, such as hormones, cytokines, killer cells, and a 
variety of chemical, physical, and viral agents. Apoptosis can run 
its course very fast, even in minutes (34 min. in Bessis' movie of 
apoptotic cells (Bessis 1958)); therefore, it is unobtrusive (rarely 
prominent) in tissue sections (Weedon, Searle et al. 1979).
"In these days of molecular pathology it is well to remember 
that the marvelous story of apoptosis was initiated by a very simple, 
almost elementary morphological observation, accessible to the 
microscopes of our great-grandfathers" (Majno and Joris 1995). 
Molecular Regulation of Apoptoais
An evolutionary perspective
Examples of apoptosis have been described throughout evolution, 
including bacteria, unicellular organisms, plants, and animals.
Recent findings (Ameisen 1996) indicate that apoptosis as a cell death 
program does exist in unicellular organisms and bacteria in contrast 
to earlier comments(Vaux and Haecker 1994), which suggested that such 
mechanism for cell suicide probably had not evolved in single-celled 
organisms. A morphologically and biochemically similar process to 
apoptosis has been described in at least four unicellular organisms, 
including the kinetoplastic parasites Trypanosoma cruzi and 
Trypanosoma brucei rhodensiense, and in the free-living slime mold 
Dictyostelium discoideum and the free-living ciliate, Tetrahymena 
thermophila (Ameisen 1996). This program could be elicited in these 
organisms by environmental stress (such as starvation) as well as by
13
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extracellular signals, which, in the case of Trypanosoma, may come 
from the multicellular host, and activate the cyclic AMP pathway 
inducing differentiation to a reversible G0/Gi arrested stage. In 
bacteria, the autolysins that participate in cell division can also 
induce self-destruction. So, if effectors of the cell cycle machinery 
can also be effectors of the self-destruction of the cell in which 
they operate, then the requirement for coupling cell survival to the 
prevention of self-destruction, or apoptosis, is as old as the origin 
of the cell (Ameisen 1996).
In plants, in order to conduct fluid, the cells from the xylem 
must die, and so must the cells that make up the tadpole's tail and 
the neurons that fail to form proper intercellular connections. The 
process of apoptosis has evolved through time not only for 
morphogenetic and developmental reasons but also as a defense 
mechanism, as a form of cellular altruism. An example would be the 
hypersensitivity response in plants in which a cell detecting a single 
bacterium not only kills itself but alerts neighboring cells, which in 
turn self-destruct (Vaux and Haecker 1994).
Caenorhabditis slogans- a model for the study of apoptosis
Caenorhabditis elegans is considered one the most important 
models for the study apoptosis and molecular biology in multicellular 
organisms. It has a reproducible embryonic development which has been 
precisely mapped. Some 1090 somatic cells are eventually formed in 
the adult of which 131 undergo programmed cell death (Ellis, Jacobson 
et al. 1991). Death of these cells is just as predictable as division 
and differentiation occurring in development. This organism has 
provided valuable information about apoptosis in mammals since it 
resembles this process in several areas, including its genetic 
connections, and thus have become a very valuable model. Mutant
14
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nematodes with defects in different parts of the cell death process 
have allowed identification of the components of the genetic pathway.
Several genes involved at different stages in developmental 
programmed cell death have been identified and classified according to 
their function(Yuan and Horvitz 1992; Yuan, Shaham et al. 1993; Yuan 
1995). Genes involved in specification of cell death include egl-1, 
ces-1, and ces-2. Those involved in programmed cell death include 
ced-3, ced-4, ced-8, and ced-1. A single gene has been identified 
for the suppression of cell death, ced-9. Several genes have been 
identified for the process of phagocytosis of dead cells, and include 
ced-1, ced-2, ced-6, ced-5, ced-1, and ced-10. And a single gene, 
nuc-1, has been coded for digestion of dead cells. Cloning and 
sequencing of some of these genes revealed that ced-9 is homologous to 
the Bcl-2 family of protein in mammals (Yuan 1995); that ced-3 is 
homologous to interleukin-ip-converting enzyme (ICE) of cysteine 
proteases(Yuan, Shaham et al. 1993); and that the deduced amino acid 
sequence of ced-4 contains two potential calcium-binding binding 
domains potentially related to unknown families of mammalian 
proteins(Yuan and Horvitz 1992); however, no counterpart of the Reaper 
equivalent, which is a very important protein in programmed cell death 
in the fruit fly, Drosophila melanogaster, has been found in 
Caenorhabditis elegans.
Signaling in Apoptosis
A cell can undergo apoptosis as a result of information received 
from its environment, which is interpreted in the context of its 
internal information, such as cell type, state of maturity, and 
developmental history (Williams and Smith 1993) . External information 
may consist of appearance or disappearance of cytokines, hormones, and 
growth factors, or of a change in intercellular interactions. Such
15
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external information received or perceived is not exclusive in 
eliciting apoptosis or survival of the cell.
Intracellular signals are often involved in the promotion of 
proliferation or differentiation even though certain intracellular 
signal pathways, such as the Fas-mediated pathway, are of particular 
importance in controlling apoptosis. The involvement of key molecules 
in the induction of apoptosis or proliferation is a recurring theme 
(PKC, p53, ceramide, c-myc) that reflects, at least in part, the 
adaptation of many signaling pathways to the control of different 
responses in different cell types and under different conditions.
Cell surface receptor-mediated mechanisms which control apoptosis 
often act through a signal transduction system that involves 
stimulation of the receptor, followed by activation of protein 
kinase/phosphatase cascades, and release of second messengers to 
upregulate or suppress the transcription of specific genes. 
Accumulation of evidence suggests that these signaling systems can 
often be redundant, can intersect, or can "crosstalk", greatly 
altering the cellular response to a given stimulus. The evidence also 
suggests that often signaling pathways converge in to one, or at least 
very few common final pathways. For example, the bcl-2 family is 
affected by a widespread spectra of apoptotic signals, which converge 
at the point of action of the corresponding gene product(s).
Fas (APO-1, CD95)
Knowledge of the control of cell death and survival has been 
gained through engaging members of the Fas/TNF receptor 1(tumor 
necrosis factor receptor 1, TNFR 1) family of cell-surface receptors 
(Nagata and Goldstein 1995), which have provided a useful model for 
the study of cell surface receptor-mediated control of apoptosis and 
cell survival. Induction of apoptosis through the Fas-Fas-L system is 
considered particularly important in the regulation of the immune 
system (Nagata and Goldstein 1995). In addition, it is believed that
16
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interaction between Fas-ligand and Fas receptor mediates the apoptotic 
cell death induced by engaging the T-cell receptor on T-lymphocyte 
cell lines (Brunner, Mogil et al. 1995).
Intestinal epithelial cells that are produced in the crypts die 
rapidly through apoptosis at the tips of the villi. Recently, the 
expression and function of Fas and FasL on the intestinal 
intraepithelial lymphocytes and intestinal epithelial cells or 
enterocytes in normal mice was examined(Inagaki-Ohara, Nishimura et 
al. 1997). It was found that both intestinal intraepithelial 
lymphocytes and intestinal epithelial cells express Fas, but that only 
intestinal intraepithelial lymphocytes expressed FasL. In this study 
it was concluded that the induction of apoptosis in enterocytes from 
the tips of the villi may occur as a result of Fas/FasL-mediated 
cytotoxicity induced by intestinal intraepithelial lymphocytes.
The primary structure of Fas, TNFR 1 and related proteins have a 
death domain, which consists of a cytoplasmic region of 60 to 70 amino 
acids, important in inducing apoptosis(Nagata and Goldstein 1995), and 
homologous to Reaper protein(White, Grether et al. 1994) in Drosophila 
melanogaster that is essential for programmed cell death in this fruit 
fly. Hale and coworkers, 1996, suggested that Fas, TNFR 1, and 
potentially other proteins were produced evolutionarily by fusion of 
exons encoding an inducer of cell death related to Reaper with those 
encoding a surface receptor. The resulting hybrid protein would then 
allow induction of apoptosis through external stimuli by linking them 
to a pre-existing cell death pathway.
Other proteins which may form part of the intracellular signals 
induced by Fas have been identified recently; these include M0RT1/FADD 
(Boldin, Varfolomeev et al. 1995) (Chinnaiyan, O'Rourke et al. 1995), 
TRADD (Hsu, Xiong et al. 1995), and RIP (Stanger, Leder et al. 1995). 
All three predicted gene products contain the death domain (Cleveland
17
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and Ihle 1995), and it is likely that these domains associate with the 
death domain of Fas and/or TNFR1.
Protein Tyrosine Kinases (PTK)
Protein Tyrosine Kinases (PTK) play a significant role in 
receptor mediated cell signaling through growth factors with intrinsic 
PTK activity, or through receptors which lack intrinsic PTK activity 
but are able to recruit and/or activate intracellular PTK in response 
to ligand stimulation. Several review articles concerning 
intracellular signaling by PTK have been published recently 
(Ziemiecki, Harpur et al. 1994; Erpel and Courtneidge 1995). Many 
cytokine receptors ( receptors for interferons, and the majority of 
the hematopoietic growth factors) do not have intrinsic tyrosine 
kinase activity. Oligomerization of the receptor following ligand 
binding results in recruitment of PTK to the intracellular domain of 
the receptor followed by activation of the signaling pathway of 
phosphorylation. Protein Tyrosine Kinases involved in this cascade 
include those from the Src family of PTK and from the Janus kinase 
family (Jak) (Ziemiecki, Harpur et al. 1994; Erpel and Courtneidge 
1995). The Jak kinases have been associated with a number of cytokine 
signaling pathways involved in the control of apoptosis(Ziemiecki, 
Harpur et al. 1994; Yousefi, Green et al. 1994) . Some of the 
cytokines so involved include interferons, interleukin-3 (IL-3), 
leukemia inhibitory factor, granulocyte/monocyte-colony stimulating 
factor (GM-CSF), erythropoeitin, and IL-2. Erythropoeitin and IL-2 
receptors are related receptors that act through tyrosine 
phosphorylation of two distinct Jak kinases, Jak2 and Jakl, 
respectively (Barber and D'Andrea 1994).
Several pieces of evidence for the increased involvement of PTK 
in the signaling pathway control of apoptosis have been published. It 
was demonstrated that ionizing radiation promoted PTK activation that 
is necessary for apoptosis in B cells (Uckun, Tuel-Ahlgren et al.
18
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1992). Cells in which the active PTK, Abl (a member of the Src 
family) was overproduced were resistant to apoptosis induced by growth 
factor withdrawal and to apoptosis induced by chemotherapeutic agents 
(Evans, Owen-Lynch et al. 1993). The ability of chronic myelogenous 
leukemia cell line K562 to undergo apoptosis was restored by antisense 
abl expression (McGahon, Bissonnette et al. 1994). In a study of 
human leukemia (Owen-Lynch, Wong et al. 1995), continuous functioning 
of the v-Abl was required for IL-3 independence, phosphorylation of 
phospholipase C (PLC), and for the Ras regulatory protein pl20 GTPase- 
activating protein function. In another study (Yao and Cooper 1995), 
the requirement for phosphatidylinositol-3-kinase in the prevention of 
apoptosis by nerve growth factor was demonstrated. And it has been 
shown that stimulation of apoptosis by the engagement of the T-cell 
receptor involves the PTK p56lclc (Somma, Nuti et al. 1995) .
Other Kinasas
Serine/threonine kinases have also been implicated in the 
control of apoptosis. The p34cdc2 kinase controls cell entry into 
mitosis by complexing with the cyclins A and B and initiating 
dissolution of the nuclear membrane and chromatin condensation, 
changes which are also noted in apoptosis (Shi, Nishioka et al. 1994). 
Blocking of p34cdc2 activity prevented DNA fragmentation characteristic 
of apoptosis (Shi, Nishioka et al. 1994).
The Ras signaling pathway
The regulation and function of Ras and Ras-related proteins have 
been summarized recently (Khosravi-Far and Der 1994; Khosravi-Far, 
Chrzanowska-Wodnicka et al. 1995). Ras is a member of a superfamily 
containing more than 50 small GTPases, functioning as GDP/GTP- 
regulated switches. They are implicated in the regulation of cellular 
proliferation, differentiation, intracellular transportation 
processes, and cytoskeletal organization. The three Ras proteins, H-, 
K-, and N-Ras, have a well studied role in signal transduction,
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linking receptor and non-receptor tyrosine kinases to down stream 
serine/threonine kinases, including the mitogen-activated protein 
(MAP)kinases. Ras itself is immediately upstream of the protein 
kinase encoded by the oncogene c-caf-1.
There are indications that the Ras/Raf/MAP kinase cascade has a
role in the inhibition of apoptosis. It has been demonstrated that the
Raf-1 kinase promoted the proliferation of IL-3-dependent myeloid 
cells and suppressed apoptosis induced by IL-3 withdrawal (Cleveland, 
Troppmair et al. 1994). Interleukin-3 can stimulate the Ras 
activation of MAP kinase via the Src homology-domain-containing (SHC) 
protein and the GTPase-activating protein through their 
phosphorylation (Owen-Lynch, Wong et al. 1995). Roles have been
established for Ras-related proteins in the signaling process relevant
to the inhibition of apoptosis, often centered on the regulation of 
the Bcl-2 protein and in the consequences of such regulation (Wang, 
Miyashita et al. 1994a; Wang, Millan et al. 1995). Some studies have 
implicated Ras-signaling in the regulation of bcl-2-inhibition of 
hematopoietic cell apoptosis following growth factor deprivation 
(Kinoshita, Yokota et al. 1995a; Kinoshita, Yokota et al. 1995b). The 
induction of mutated ras mRNA, using an inducible expression vector, 
restored the levels of bcl-2 mRNA following IL-3 deprivation, and also 
blocked the degradation of Bcl-2 protein that had been previously seen 
following IL-3 deprivation (Kinoshita, Yokota et al. 1995b). Rasval‘" 
could induce mRNA encoding the Bcl-2-related protein Bcl-xL, though 
neither the induction of Rasva112 nor IL-3 deprivation affected the 
level of mRNA of another Bcl-2-related protein, Bax. As the induction 
of ras mRNA preceded that of the bcl-2 and bcl-xL mRNA, and was 
sustained at a level which correlated with that for Bcl-2 and Bcl-xL 
proteins, it was concluded that this mechanism of regulation of
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Bcl-2/Bcl-xL by Ras appeared to be fundamental to IL-3/GM-CSF 
inhibition of apoptosis (Kinoshita, Yokota et al. 1995b).
Protein kinase C and Calcium
Surface receptors are coupled to the Ca2* signaling pathways 
through G proteins and PTK, which activate phospholipases C (PLC) and 
D (PLD) by the hydrolysis of phosphatidylinositol 4,5-bisphosphate 
producing inositol trisphosphate and diacylglycerol. Inositol 
trisphosphate promotes the release of Ca2f from the endoplasmic 
reticulum and Ca2*" influx through the plasma membrane; diacylglycerol 
activates the serine/threonine kinase and the protein kinase C (PKC).
In thymocytes, chemicals that stimulate increases in PLC and 
intracellular calcium concentration can induce endonuclease activation 
and cell death (Smith, Williams et al. 1989). It is known that the 
PKC signaling pathway can interact with other signaling pathways. PKC 
activation results in the rapid phosphorylation and activation of c- 
Raf kinase, which in turn activates the protein kinase cascade through 
phosphorylation and activation of MAP kinases (Kyriakis, App et al.
1992). Further analysis provided evidence for the interaction of PKC 
and the protein kinase A signal transduction pathways (Ojeda, Folch et 
al. 1995) .
This crosstalk between signaling pathways may account for the 
apparent contradictions between the different molecules, such as PKC, 
in the induction of proliferation and apoptosis. These observations 
in addition to the involvement of the phosphatidylinositol 4,5- 
bisphosphate and the sphingomyelin metabolic pathways in the 
activation of PKC, implicate PKC in the regulation of apoptosis in 
many cells. Experimental evidence suggesting that PKC is involved in 
apoptosis as well as in cell differentiation and proliferation is 
largely based in the use of phorbol esters as activators of PKC 
(McConkey, Nicotera et al. 1994). Incubation of thymocytes with 
phorbol esters has been reported to induce and to block apoptosis
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(McConkey, Nicotera et al. 1994). Similarly, staurosporin can induce 
apoptosis (Jacobson, Burne et al. 1993) and block phorbol ester- 
induced apoptosis (Munn, Beall et al. 1995). Also, PKC activators, 
such as 12-tetradecanoyl-phorbol 13-acetate, are able to inhibit 
apoptosis induced by ceramide (Hannun and Obeid 1995) and nitric oxide 
(Messmer, Lapetina et al. 1995). These observations add to the 
complex interactions of the several pathways regulating apoptosis.
Some reports have demonstrated a relationship between increased 
cytosolic calcium and apoptosis. Azzoni, 1995, observed that coupling 
of the IgG receptor, FcyRIII-A, on IL-2-activated natural killer cells 
leads to stimulation of PTK p56lclt; this was followed by increased 
release of calcium from intracellular stores, and ultimately induced 
apoptosis in these cells; subsequently, it was concluded that such 
increase in intracellular calcium was necessary for Fcg-receptor- 
mediated signaling, including transcription of other cytokine genes 
(Azzoni, Anegon et al. 1995).
Other reports have not detected such increases in intracellular 
calcium concentration. No correlation was found between early 
increases in intracellular calcium concentration and apoptosis in 
thymocytes treated with gliotoxin, which may act through Ras, and 
thapsigargin, an inhibitor of endoplasmic reticulum calcium ATPase 
(Beaver and Waring 1994).
Perhaps, the real importance of the role of calcium and its 
consequences in apoptosis lies in the occurrence of more subtle 
changes in redistribution of its intracellular levels.
Ceramide
Ceramide is a hydrophilic component of all sphingolipids. Its 
role in the induction of proliferation and apoptosis was recently 
reviewed (Kolesnick and Fuks 1995) as well as its role as a signaling 
molecule (Hannun and Obeid 1995) (Pushkareva, Obeid et al. 1995)
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(Wright and Kolesnick 1995). Ceramide is a second messenger that is 
released after hydrolysis of membrane sphingolipids, especially 
sphingomyelin, and that activates a protein kinase cascade. Ceramide 
inhibits growth and induces differentiation of leukemia cells, 
modulates protein phosphorylation, and regulates gene transcription. 
The IL-1, interferon-g, and tumor necrosis-a cytokine-stimulated 
pathways are likely to involve ceramide (Hannun and Obeid 1995). 
Activation of the sphingomyelin pathway with the subsequent release of 
ceramide mimics the apoptotic effects of TNF-a (Jarvis, Kolesnick et 
al. 1994). Ceramide appears to target the downstream, stress- 
activated protein kinase (SAPK) pathway, a proposed key target for the 
control of apoptosis (Rowan and Fisher 1997). But the ceramide/SAPK 
signaling may not be sufficient to for induction of apoptosis by 
themselves. It has been shown that Bcl-2 and cysteine protease 
inhibitors effectively block ceramide-induced apoptosis (Zhang, Alter 
et al. 1996). Other signaling molecules, such as 
phosphatidylinositol-3 kinase, can also give protection against 
apoptosis and not be involved in the ceramide/SAPK pathway (Vemuri and 
McMorris 1996).
Cyclic Adenosine 3',5'-Monophosphate (cAMP)
Cyclic adenosine 3',5'-monophosphate (cAMP) acts mostly through 
cAMP-dependent kinase (Spaulding 1993). Increases of cAMP could 
either stimulate apoptosis, probably through a calcium-dependent 
protein kinase, or inhibit apoptosis; therefore, elevations in cAMP, 
as in other signaling pathway components, may have different effects 
on different cells. This dual cAMP signaling occurs via cAMP- 
dependent protein kinase A (PKA), which exists as two isoenzymes, 
type-I and type-II, respectively. Each PKA isoenzyme is composed of 
two catalytic subunits and an inhibitory regulatory subunit (RI, RII) 
containing two binding sites (A, B) for cAMP. The type of PKA 
isoenzyme involved in signaling is dictated by whether RI or RII is
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combined with the catalytic domain subunit (RI-type-I, RII-type-II). 
Maintenance of the ratio between RI and RII is critical for the 
maintenance of homeostasis in normal cells, and departures from this 
balanced ratio is important in the pathogenesis of various human 
diseases, including cancer (Ally, Tortora et al. 1988; Cho-Chung
1990). In a recently published study, the effects of cAMP analogs 
were studied on the malignant human glioma cell line A-172 and primary 
glioma cell cultures and found that modulation of the cAMP/PKA pathway 
induce decreased proliferation, increased differentiation, and 
subsequent apoptosis of these cells (Chen, Hinton et al. 1988). In a 
study of apoptosis-defective mutants, it was demonstrated that 
apoptosis induced by cAMP, dexamethasone, and ionizing radiation, 
merge into a common pathway prior to the point where Bcl-2 exerts its 
antiapoptotic effect (McConkey, Nicotera et al. 1994).
Oxygon Radicals and Oxidative Stress
Oxidative stress is important in both cytotoxicity and in 
cellular activation. The role of oxygen radicals and oxidation in 
apoptosis have been reviewed(McConkey, Nicotera et al. 1994); Hydrogen 
peroxide can activate the transcription of the nuclear factor NF- 
kB(McConkey, Nicotera et al. 1994). It has been suggested that 
reactive oxygen species could be important in apoptosis(Hockenbery, 
Oltavi et al. 1993). In a study where apoptosis was induced in 
neurons after deprivation of nerve growth factor (NGF), a transient 
increase in reactive oxygen species was noted, and that superoxide 
dismutase protected such cells against apoptosis(Greenlund, Deckwerth 
et al. 1995). In another study it was reported that thymocyte 
apoptosis could be inhibited by chemicals with antioxidant 
properties(Slater, Nobel et al. 1995).
Evidence that oxygen radicals are not generally required for 
apoptosis has been provided(Jacobson and Raff 1995; Muschel, Bernhard
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et al. 1995); these investigators concluded that apoptosis induced by 
withdrawal of growth factor and the protection provided against 
apoptosis by Bcl-2 did not require reactive oxygen species.
Nitric oxide is also important in inducing apoptosis in some 
situations(Mannick, Asano et al. 1994), (Messmer, Lapetina et al.
1995). It has been suggested that nitric oxide could amplify calcium- 
induced gene transcription in neural cells, and that nitric oxide- 
signaling may be linked to the expression of bcl-2{Genaro, Hortelano 
et al. 1995).
Insulin Growth Factor-1 and Insulin Growth Factor-1 Recaptor
Several pieces of evidence support a direct role for inhibition 
of apoptosis by insulin growth factor-1 (IGF-1) receptor activation 
(see summary by Rubin and Baserga 1995). It has been demonstrated 
that IGF-1 can prevent apoptosis induced by over expression of c-myc 
in rat-1 fibroblasts, in IL-3-dependent hematopoietic cells after IL-3 
removal, of BALB/c3T3 fibroblasts after exposure to the topoisomerase 
inhibitor, etoposide, or simply after serum deprivation of contact- 
inhibited quiescent cultures. The mechanism of action by which IGF-1 
receptor protects cells is poorly understood. It is suggested that 
IGF-1 exerts its antiapoptotic actions through phosphorylation of pre­
formed cytosolic mediators whose synthesis is regulated by other 
growth factors (Rubin and Baserga 1995).
Influence of Feed on Rodent Liver Apoptosis
Feeding regimens have been found to have a profound effect on 
the occurrence of apoptosis in normal and hyperplastic rodent liver 
(reviewed by Bursch, Grasl-Kraupp et al. 1994) . Prolonged fasting or 
severe starvation increases the rate of apoptosis in rat liver. In 
contrast, food uptake exerts an inhibitory effect on the occurrence of 
apoptosis during the regression of liver hyperplasia (Schulte-Hermann, 
Bursh et al. 1988; Grasl-Kraupp, Bursh et al. 1994). It was noted 
that the extent and kinetics of the food-mediated inhibition of
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apoptosis is very similar to that seen after mitogen treatment 
experiments, and that the energy uptake itself was the most effective 
factor in mediating such inhibitory effect on apoptosis, rather than 
the dietary components of the diet. In addition, the cyclic eating 
behavior of rats seems to result in a diurnal rhythm of cell turnover, 
with a peak of apoptoses occurring shortly before feeding and the peak 
of cell proliferation occurring at about 12 hours later (Schulte- 
Hermann 1977).
Regulation of Apoptosis by Transforming Growth Factor-^
Transforming Growth Factor-p (TGF-P) is a potent growth inhibitor 
and apoptotic inducer for hepatocytes via autocrine upregulation and 
activation (Bursch, Grasl-Kraupp et al. 1994; Schulte-Hermann, Grasl- 
Kraupp et al. 1995; Bauer 1996; Santoni-Rugiu, Jensen et al. 1998). 
Furthermore, data has been presented recently to indicate that TGF-fJ- 
treated normal cells are able to eliminate transformed cells by 
induction of apoptosis (Bauer 1996), which supports the model that 
control of transformed cells is performed by neighboring, normal 
cells. Moreover, the TGF-p-induced signal pathway in normal cells, 
leading to the production of a short-lived apoptosis-inducing factor, 
as well as the specific interaction of this factor with transformed 
cells depend on the action of reactive oxygen species (Bauer 1996) . 
Sensitivity to the induction of apoptosis seems to be a common feature 
associated with the transformed state, independent of the originating 
transforming principle (Bauer 1996) . Therefore, tumor development 
should require either interference with the process of apoptosis or 
the acquisition of resistance to it (Bauer 1996). One may see how 
interfering substances, such as antioxidants, and how genetic systems, 
such as the Bcl-2 pathway, may protect transformed cells form their 
cellular environment as discussed in the extensive review by Bauer, 
1996.
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Mammalian ced-9-Related Apoptosis-Modulating Genes
Several mammalian ced-9-related apoptosis-modulating genes have 
been found to have significant amino acid sequence similarity. This 
most likely indicates that apoptosis control in mammals is one of 
great complexity. Involvement of similar gene families between 
nematodes and mammals suggest that related genes may regulate cell 
death in other pluricellular organisms, including fish.
Human genes encoding Ced-9 related proteins reported so far 
include (not an inclusive list) bcl-2 (Tsujimoto and Croce 1986), bcl- 
x (Boise, Gonzctlez-Garcia et al. 1993), bax (Oltvai, Milliman et al. 
1993), mcl-1 (Kozopas, Yang et al. 1993), bak (Chittenden, Harrington
et al. 1995) (Farrow, White et al. 1995) (Keifer, Brauer et al. 1995),
bak-2 (Keifer, Brauer et al. 1995), bak-3 (Keifer, Brauer et al.
1995), and bad (Kitada, Krajewska et al. 1998; Yang, Zha et al.
1995a).
In addition to murine homologues of bcl-2, bcl-x, bax, mcl-1, 
bak, and bad one additional protein which has not been reported in for 
humans is Al (Lin, Orlofsky et al. 1993). The gene bfl-1 (Choi, Park
et al. 1995) may represent the human homologue of the mouse Al gene.
Bik (Boyd, Gallo et al. 1995) has also been reported as a death- 
inducing protein, which shares BH3, a 9 amino acid domain, with Bax 
and Bak.
Conservation between humans and birds is shown by the presence 
of homologues of at least of bcl-2 and bcl-x in chickens. An 
additional member of the family without known mammalian homologue, 
NR-13, has been reported in the quail (Gillet, Guerin et al. 1995).
Mammalian viruses with genes encoding Ced-9/Bcl-2 related 
proteins include: Epstein-Barr virus-BHRF-1 gene (Pearson, Luka et al. 
1987); African swine fever virus LMW5-HL gene (Neilan, Lu et al.
1993), also known as A179L (Yanez, Rodriguez et al. 1995); Herpes
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saimiri-0RF16 gene (Smith 1995). It has been suggested that these 
viral proteins, as with other viral proteins that are unrelated to 
Ced-9, prevent or delay apoptosis of infected cells in order to 
prolong viral replication(Alnemri, Robertson et al. 1992).
Comparison of the amino acid sequences of these Ced-9-related 
proteins has identified two well defined regions with similar 
sequences designated BH1 and BH2 (Oltvai, Milliman et al. 1993;
Williams and Smith 1993; Yin, Oltvai et al. 1994). It has been shown 
that by changing amino acids in either BH1 or BH2 region, the ability 
of the human Bcl-2 protein to inhibit apoptosis is blocked(Sato,
Hanada et al. 1994) (Yin, Oltvai et al. 1994).
In the nematode Caenorhabditis elegans, the ced-9 gene product 
only encodes for a negative regulator (i.e., an inhibitor) of cell 
death(Yuan 1995). On the other hand, mammalian ced-9-related gene 
families encode for both positive (promoter) and negative (inhibitor) 
regulators of cell death. Bcl-2 is a negative regulator; for example, 
it prevents IL-3-dependent cells from undergoing apoptosis after 
deprivation of IL-3 (Vaux, Cory et al. 1988). Bcl-Xj., the largest 
protein product of the human bcl-x gene, is a negative regulator, as 
it prevents IL-3-dependent cells from undergoing apoptosis after 
withdrawal of IL-3 (Boise, Gonz&lez-Garcia et al. 1993). Bcl-xs, the 
smallest protein product of the human bcl-x gene, is a positive 
regulator, as it allows apoptosis to proceed in IL-3-dependent cells 
after deprivation of IL-3, even in the presence of Bcl-2 (Boise, 
Gonz&lez-Garcia et al. 1993).
Different tissues show differential expression of Bcl-xL and Bcl- 
xs. Most tissues express Bcl-xL, but tissues with a high rate of 
apoptosis also express variable levels of Bcl-xs (Boise, Gonz&lez- 
Garcia et al. 1993; Krajewski, Krajewska et al. 1994a).
Human Mcl-1 protein is a negative regulator of cell death and, 
like Bcl-2 and Bcl-xL, can delay death of cells over-expressing c-Myc
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(Reynolds, Yang et al. 1994). Mcl-1 is expressed in epithelial cells 
that are more differentiated than those expressing Bcl-2 and in 
various types of muscle, lymph node germinal centers, and 
differentiating myeloid cells(Krajewski, Bodrug et al. 1995). Mcl-1 
has a short half life of about an hour (Yang, Kozopas et al. 1995b), 
that may allow rapid modulation of the susceptibility of 
differentiating cells to apoptosis (Krajewski, Bodrug et al. 1995).
The principal product of human bax, Baxa, opposes the action of 
Bcl-2, and its overexpression allows apoptosis to proceed after IL-3 
withdrawal from IL-3-dependent cells even in the presence of 
dysregulated expression of Bcl-2 (Oltvai, Milliman et al. 1993). Bax 
is expressed more widely in adult mouse than Bcl-2, especially in cell 
types that have a high rate of apoptosis (Krajewski, Krajewska et al. 
1994b).
Like Bax, Bak accelerates apoptosis of IL-3-deprived cells and 
partially blocks Bcl-2 inhibition of apoptosis (Chittenden, Harrington 
et al. 1995). Bak also accelerates apoptosis in growth factor- 
deprived neurons and blocks the protective effect of E1B 19-kDa 
protein (Farrow, White et al. 1995), but it appears to be able to 
inhibit apoptosis of serum-deprived Epstein-Barr virus transformed 
cell lines (Keifer, Brauer et al. 1995).
The human and murine bad products promote apoptosis like Bax and 
Bak. Bad allows apoptosis to proceed in IL-3-dependent cells after 
withdrawal of IL-3, but not in the presence of Bcl-2 (Yang, Zha et al. 
1995a; Kitada, Krajewska et al. 1998) . Bad can influence the relative 
ability of Bcl-xL and Bcl-2 to prevent apoptosis (Yang, Zha et al. 
1995a; Kitada, Krajewska et al. 1998).
The murine A1 gene is induced by granulocyte/monocyte-colony 
stimulating factor (GM-CSF) and its role in regulation of apoptosis 
has not been reported (Lin, Orlofsky et al. 1993).
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Transgenic mice
Homozygous ced-9 loss-of-function mutant alleles are lethal in 
Caenorhabditis elegans because of massive cell death during embryonic 
development (Yuan 1995). Use of transgenic mice deficient in Bcl-2 or 
Bcl-x or Bax have provided sufficient evidence to suggest that in 
mammals, different members of the family of ced-9-related genes are 
responsible for controlling developmental cell death in different 
tissues. Homozygous bcl-2 null mice (one that lacks both Bcl-2a and 
Bcl-2P splicing variants) develop nearly normal, but abnormalities 
become evident after birth in various tissues due to defects in 
survival of particular cell types (Nakayama, Negishi et al. 1994) 
(Sorenson, Rogers et al. 1995). Developmental abnormalities are noted 
in the kidney as polycystic kidneys, due to excessive apoptosis during 
metanephric development, and in the small intestine as accelerated 
loss of epithelial cells and reduced number of mitotic precursors. 
Abnormalities are also noted in the development of lymphoid tissue as 
splenic and thymic atrophy due to increased lymphocyte sensitivity to 
apoptosis. Another abnormality noted is the development of 
hypopigmented coat in mice after the first hair follicle cycle due to 
a defect in melanocyte survival. Homozygous bcl-x null mice die at 
about day 13 due to massive apoptosis of hematopoietic cells, 
hepatocytes, and of central nervous system post-mitotic neurons; 
otherwise, the mice appeared normal(Motoyama, Wang et al. 1995). 
Homozygous bax-null mice are viable and show nearly normal 
development; however, these mice show T- and B-cell hyperplasia; the 
females show excess granulosa cells in atretic ovarian follicles; and 
males are infertile since they lack mature sperm and have massive 
apoptosis of germinal cells(Knudson, Tung et al. 1995).
One may conclude that none of these genes, bcl-2, bcl-x, or 
bax, play the same critical role in the control or modulation of
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developmental cell survival in mammals as the ced-9 gene does in the 
nematode Caenorhabditis elegans ; thus, in mammals each gene may be 
needed for the survival or deletion of a particular cell in a 
particular organ at a determined time.
Control of Bcl-2 and Bax by the Tumor Suppressor p53 Gene 
The tumor suppressor gene, p53, is implicated in cell cycle 
arrest and apoptosis following DNA damage(Kastan, Onyekwere et al.
1991). p53 is a positive regulator of bax expression and a negative
regulator bcl-2 expression, and p53 null-mice have high levels of Bcl- 
2 and lower levels of Bax than normal mice in several tissues 
(Miyashita, Krajewski et al. 1994b) (Selvakumaran, Lin et al. 1994). 
p53 also causes up-regulation of bax expression following DNA damage 
with ionizing radiation (Selvakumaran, Lin et al. 1994; Miyashita, 
Krajewski et al. 1994b).
Studies of homodimer and heterodimer formation by ced-9-related 
proteins have allowed investigation of how the internal state of a 
cell may control the apoptotic response through the ratio of apoptosis 
inhibiting to apoptosis promoting proteins (Sato, Hanada et al. 1994) 
(Chittenden, Harrington et al. 1995). The Bcl-2/Bax ratio in a cell 
acts as a "rheostat", which regulates its susceptibility to 
apoptosis(Korsmeyer, Shutter et al. 1993); p53 can shift or reset
this "rheostat" following DNA damage by repressing bcl-2 and inducing 
bax expression (Selvakumaran, Lin et al. 1994; Miyashita, Harigai et 
al. 1994a; Miyashita, Krajewski et al. 1994b; Miyashita and Reed 
1995) . Alternatively, the ratio of Bcl-xL/Bcl-xs might be the one 
altered or shifted by differential mRNA alternative splicing of Bcl-x 
(Boise, Gonzalez-Garcia et al. 1993).
In general, the ratio of apoptosis-suppressing (Bcl-2, Bcl-xL, 
Mcl-1) to apoptosis-promoting (Bax, Bcl-xs, Bak, Bad) Ced-9-related 
proteins in mammalian cells may through their differential expression
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control their susceptibility to undergo apoptosis. Thus, these 
proteins may act by regulating the susceptibility of cells to 
apoptosis during development and during differentiation of renewing 
cell populations in different tissues.
Cellular Localization of Ced-9-Related Proteins 
Bcl-2a is located on the cytoplasmic surface of the nuclear 
envelope, outer mitochondrial membrane, and endoplasmic reticulum 
(Jacobson, Burne et al. 1993; Krajewski, Tanaka et al. 1993; Akao, 
Otsuki et al. 1994; Lithgow, van Driel et al. 1994). Bcl-2fi, on the 
other hand, is largely cytosolic (Tanaka, Saito et al. 1993). Several 
investigators have reported that Bcl-2 localizes strongly to the 
nucleus during mitosis and associates with the chromosomes during 
prophase, metaphase, and anaphase before disappearing at telophase 
(Lu, Hanby et al. 1994; Willingham and Bhalla 1994). Bcl-XL and Bcl-xs 
are predominantly mitochondrial proteins(Fang, Rivard et al. 1994), 
while Bcl-xL is located mainly at the periphery of the mitochondria 
and nuclear envelope (Gonzdlez-Garcia, Perez-Ballestero et al. 1994).
The localization of Mcl-1 has been described as predominantly 
mitochondrial with less nuclear association than Bcl-2(Krajewski, 
Bodrug et al. 1995; Yang, Kozopas et al. 1995b).
Proteasas in Apoptosis
Interleukin-ip-Converting Enzyme (ICE) and Caspases 
Yuan, 1993, observed that Caenorhabditis elegans Ced-3 has 
significant sequence similarity to the human interleukin-ip-converting 
enzyme (ICE), and that this similarity suggested a role for ICE or 
ICE-like proteases in the control of apoptosis.
In mammals Ced-3 homologues are a family of at least 10 cysteine 
proteases with aspartate specificity now called caspases (Alnemri, 
Livingston et al. 1996; Goldstein 1997). Caspase activation is a 
widespread occurrence in apoptosis, and its overexpression is
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sufficient to induce apoptosis; there are examples where caspase 
inhibition is sufficient to block apoptosis (Enari, Hug et al. 1995; 
Los, Van de Craen et al. 1995). Caspases show strong preference for 
cleavage at a peptide sequence with an Asp residue at the Px position; 
these may be inactivated by the protease inhibitors N-tosyl-L- 
phenylalanine chloromethane and 3,4-dichloroisocoumarin (Wilson, Black 
et al. 1994); and can also be inhibited by CrmA, a 38-kDa protein 
encoded by the cowpox virus (Ray, Black et al. 1992), which can 
inhibit apoptosis.
The expanding caspase family consists of proteins with sequence 
similarity to Ced-3/caspases. The TX protein (Faucheu, Diu et al. 
1995) has the highest sequence similarity to Ced-3/caspases; it shows 
proteolytic activity against caspases and itself but not against 
proIL-lb. Transfection of TX into COS cells induces apoptosis. TX is 
expressed in all adult human tissues, except in the brain. Other 
names for TX include ICErell-II (Munday, Vaillancourt et al. 1995) and 
Ich-2 (Karnens, Paskind et al. 1995).
The nedd-2 gene is highly expressed during embryonic development 
of mouse brain and down regulated in the adult brain; it encodes for a 
caspase protein, and its overexpression results in apoptosis in mouse 
fibroblast and mouse neuroblastoma cell lines (Kumar, Tomooka et al. 
1992; Kumar, Kinoshita et al. 1994). Human homologues are Ich-1L and 
IchlS; overexpression of Ich-1L induces apoptosis in Rat-1 fibroblasts, 
and overexpression of Ichls inhibits apoptosis in Rat-1 
fibroblasts(Wang, Miura et al. 1994b).
The 70-kDa Ul-specific small ribonucleoprotein is specifically 
cleaved in apoptotic cells to a 40-kDa protein by an unidentified 
caspase-like protease(Casiola-Rosen, Miller et al. 1994). A caspase- 
like protease that can cleave poly(ADP-ribose)polymerase (PARP) has 
been shown to play an important role in the early stages of apoptosis 
(Nicholson, Ali et al. 1995). PARP is involved in DNA repair and in
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the supervision of genome structure and integrity. The cleavage of 
PARP results in nuclear and DNA fragmentation (Lazebnik, Kaufmann et 
al. 1994). PARP exerts a negative regulatory effect over a Ca^/Mg2*- 
dependent endonuclease implicated in the internucleosomal DNA cleavage 
that occurs in apoptosis; loss of PARP function could result in 
activation of this nuclease in dying cells(Arends, Morris et al.
1990).
CPP32 (or Yama, after the Hindu god of death) has been 
identified as the precursor of the protease apopain, which cleaves 
PARP (Fernandes-Alnemri, Litwack et al. 1994; Tewari, Quan et al.
1995a) (Nicholson, Ali et al. 1995). The cytotoxic T-lymphocyte- 
derived granzyme-B can also cleave CPP32 be into its active form, 
apopain(Darmon, Nicholson et al. 1995).
The mammalian gene mch-2 , also related to the ced-3 gene, has 
been cloned from human Jurkat T-lymphocytes (Fernandes-Alnemri,
Litwack et al. 1995); its product, Mch-2, has highest sequence 
similarity to CPP32. Mch-2 is more related to Ced-3 than any other 
member of the caspase family and can also cleave PARP.
Caspases seem to have an active role in Fas-mediated and TNF- 
induced apoptosis. Induction of apoptosis by anti-Fas antibody is 
inhibited by caspase tetrapeptide inhibitors, and anti-Fas antibody 
fails to induce apoptosis in c.aspase-deficient thymocytes from 
caspase-knockout mice (Kuida, Lippke et al. 1995). Their involvement 
in Fas-mediated apoptosis has been demonstrated in several cell lines 
including the B-cell lymphoma BJAB and human MCF-7 breast carcinoma 
cell lines (Tewari and Dixit 1995) , W4 and human Jurkat cell lines 
(Enari, Hug et al. 1995), and the L929-APO-1 and B-lymphoblastoid SKW 
6.4 cell lines (Los, Van de Craen et al. 1995).
The involvement of the caspase family in apoptosis induced by 
other mechanisms has been evaluated. Protease inhibitors, which 
preferentially inhibit caspases and caspase-like proteases, have been
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used to block apoptosis of human myeloid leukemia U937 cells induced 
by TNF and anti-Fas antibodies as well as that induced by etoposide 
and camptothecin(Mashima, Naito et al. 1995). A caspase-knockout mouse 
has been produced which displayed an apparently normal phenotype for 
the first 16 weeks of life; this suggested that caspases are not 
required during development, and that normal negative selection of 
auto-reactive T-cells appears to occur in the absence of caspases 
(Kuida, Lippke et al. 1995). It has been demonstrated that the lack 
of caspases in isolated caspase-deficient thymocytes, which conferred 
resistance to anti-Fas antibodies, had no effect on apoptosis induced 
by glucocorticoids, aging, or ionizing radiation, nor on ATP-induced 
macrophage apoptosis, thus, suggesting that caspases by themselves do 
not have an essential role in apoptosis in all situations (Kuida, 
Lippke et al. 1995; Li, Allen et al. 1995).
In contrast, Bcl-2 and caspases probably affect or are involved 
in the same apoptosis pathway (Miura, Zhu et al. 1993; Goldstein 
1997). In the study done by Miura and coworkers, 1993 (Miura, Zhu et 
al. 1993), it was demonstrated that cell death of Rat-1 fibroblasts 
caused by caspase overexpression could be suppressed by bcl-2 
overexpression, and suggested that either caspase/ICE lies upstream of 
Bcl-2 or that they act in concert.
Based on the information available from several published 
reports(Miura, Zhu et al. 1993; Chinnaiyan, O'Rourke et al. 1997; 
Goldstein 1997; Kluck, Bossy-Wetzel et al. 1997; Wu, Wallen et al. 
1997; Yang, Liu et al. 1997), an apoptosis cascade could be divided 
into several stages. First, death-triggering extracellular agents 
induce a series of multiple signaling pathways that convey into a 
central control and execution point. At this point, activation of 
Ced-3/caspases occurs, a step that is under the regulation of Ced- 
9/Bcl-2 proteins; presumably the Ced-4 homologue is also involved at 
this stage. Because Bcl-2 is mainly localized on the mitochondrial
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membrane, it is suggested that the mitochondria may play an important 
part at this level. This is followed by a downstream caspase 
activation cascade that leads eventually to the characteristic 
morphological and biochemical features of apoptosis. It has recently 
been shown that Ced-4 (or its mammalian counterpart) participates as 
the molecular link between the family of Bcl-2 and the caspases 
(Chinnaiyan, O'Rourke et al. 1997; Wu, Wallen et al. 1997).
Chinnaiyan, 1997, demonstrated that overexpression of transfected, C. 
elegans Ced-4 into mammalian cells leads to apoptosis, and that this 
process could be blocked by the overexpression of Bcl-xL and by caspase 
inhibitors. Thus, indicating that in mammalian cells Ced-4 causes 
apoptosis through caspase activation, a process under the modulation 
by the Bcl-2 family members. Chinnaiyan, 1997, also demonstrated a 
direct physical interaction between the proteins Ced-4 and Ced-9 (or 
Bcl-xL) and the proteins Ced-4 and Ced-3 (or the mammalian caspases ICE 
and FLICE, but not the CPP32 or Mch-2 proteins). Wu, 1997, showed that 
the expression of Ced-4 was diffuse in the cytoplasm when Ced-4 was 
expressed in isolation, whereas it formed a compact granular pattern 
when Ced-9 was co-expressed with Ced-4, and that Ced-4 shifted from 
the cytosol to the mitochondria upon expression of Ced-9. But because 
of Chinnaiyan's findings, 1997, which showed that the binding of Ced- 
9 to Ced-4 did not prevent the binding of Ced-4 to Ced-3, when Ced-9 
directs Ced-4 to the mitochondria, Ced-9 must also bring Ced-3 there 
as well. During such event, Ced-9 also modifies Ced-4 to ultimately 
prevent Ced-3/caspase activation and subsequent apoptotic structural 
alterations.
Considering all of this information, a simple overview of the 
events involved may be summarized as follows; Ced-9/Bcl-2, at the 
mitochondrial membrane, binds and modulates Ced-4, which in turn binds 
to Ced-3/caspases. This binding of Ced-3/caspases may lead to caspase 
activation if Ced-4 is not bound by Ced-9/Bcl-2. To this simple
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scheme other observations may be added. For instance, Bcl-2 appears 
to drag the signaling molecule Raf-1 kinase. Bad, which is 
proapoptotic though heterodimerization with either Bcl-2 or Bcl-xL, can 
be phospholrylated by Raf-1 (Wang, Rapp et al. 1996) at the 
mitochondrial membrane. Phosphorylated Bad can not heterodimerize 
with Bcl-2, allowing, thus, Bcl-2-driven survival. Therefore, 
postranslational modifications of some members of the Bcl-2 family can 
regulate cell death in a mitochondrial environment.
However, Ced-4 may not be the only intermediate between Bcl-2 
proteins and caspases. Cytochrome-c (Cyt-c) released from the 
mitochondria may also be as important (Kluck, Bossy-Wetzel et al.
1997; Yang, Liu et al. 1997). These investigators showed that Bcl-2 
regulates the release of Cyt-c from the mitochondria, and such event 
is required for further caspase activation and subsequent apoptotic 
effects.
Another possible indirect connection between Bcl-2 proteins and 
caspases via mitochondria has been suggested (Kroemer, Zamzami et al. 
1997). A loss of mitochondrial membrane potential occurs during cell 
death. The permeability transition leads to the release of a 
molecule, called AIF (apoptosis-inducing factor) (Bauer 1996;
Goldstein 1997; Kroemer, Zamzami et al. 1997), which appears to act as 
a caspase-inhibitor-sensitive protease, leading to caspase activation 
and apoptosis. Such permeability transition can be blocked by caspase 
inhibitors under certain circumstances, thus, suggesting that it may 
require the first steps of the caspase activation cascade (Kroemer, 
Zamzami et al. 1997) . The control of caspase activation by Bcl-2 may 
not account for all of its possible effects on apoptosis, however. 
Bcl-xL by itself is able to form ion channels in membranes (Minn,
Velez et al. 1997), and hyperexpression of Bax can lead to caspase- 
independent apoptosis (Xiang, Chao et al. 1996). The effects of the 
Bcl-2 family members may parallel those of perforin, a channel-forming
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molecule in granules of cytotoxic T-lymphocytes, which kill target 
cells after granule exocytosis. At high concentrations, perforin is 
able to destroy the target cell by itself, through accidental cell 
death rather than through an apoptotic cell death. At lower 
concentrations, however, perforin allows another granule protein, the 
serine esterase granzyme B, to leave an unidentified target cell 
organelle to activate caspases and, subsequently, apoptosis (Froelich, 
Orth et al. 1996). Both Bcl-2 family proteins and perforin are 
channel-formers, can by themselves trigger cell death at high 
concentrations, and both, at lower concentrations, can lead to the 
release from intracellular organelles of molecules (Cyt-c and granzyme 
B, respectively) that will lead to caspase activation and apoptosis 
(Goldstein 1997) . Moreover, it was recently demonstrated that 
caspases, specifically caspase-3 (CPP32), can cleave the loop domain 
of Bcl-2 and further activate downstream caspases as a Bax-like 
effector and contribute to further amplification of the caspase 
cascade leading to apoptosis (Cheng, Kirsch et al. 1997). Although 
Bcl-2 is presumed to inhibit caspase activation by acting upstream of 
caspases, Bcl-2 may also be a downstream death substrate of caspases, 
suggesting the existence of a feedback loop between Bcl-2 and caspases 
(Cheng, Kirsch et al. 1997). The observation that Bcl-2 cannot 
inhibit apoptosis in some situations implies that specific caspases 
may bypass the pathway inhibited by Bcl-2. In this scenario, Cheng 
and co-workers, 1997, concluded that activation of a subset of 
caspases that are insensitive to Bcl-2 may also promote cleavage of 
Bcl-2, not only inactivating its antiapoptotic function but also 
enhancing apoptosis.
Further Involvement of Proteases in Apoptosis
Other proteases expressed during apoptosis include calpain, 
cathepsin B and D, collagenase, tissue type and urokinase type 
plasminogen activators, and pre-existing 24-kDa protease (Guenette,
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Mooibroek et al. 1994; Squier, Miller et al. 1994; Wright, Wei et al.
1994). Calpain is activated prior to the appearance of morphological 
changes of apoptosis and DNA fragmentation in dexamethasone treated 
thymocytes (Squier, Miller et al. 1994). In-vitro substrates for 
calpain include cytoskeletal proteins, growth factor receptors, 
transcription factors, and signal transducing enzymes. Cathepsin-B is 
a thiol protease, whose expression is increased in apoptotic 
epithelial cells in regressing rat prostate and mammary glands 
(Guenette, Mooibroek et al. 1994). This protease is necessary for the 
destruction of extracellular matrix and degradation of basement 
membrane components, including collagen, fibronectin, and 
proteoglycans. Urokinase-type plasminogen, a serine protease, may be 
involved in mediating apoptosis induced by tumor necrosis factor (TNF) 
(Kumar and Baglioni 1991). Plasminogen activator inhibitor type-2 
(PAI-2), whose only known target is urokinase-type plasminogen 
activator, induces resistance to TNF-induced apoptosis. Pre-existing 
24-kDa protease is involved in TNF- and UV light-induced DNA 
fragmentation in U937 histiocytic lymphoma cells as well as in BT20 
breast carcinoma, HL-60 myelocytic leukemia cells, and 3T3 fibroblasts 
(Wright, Wei et al. 1994).
Serine and cysteine proteases are implicated as mediators of 
apoptosis in a variety of cells including thymocytes (Weaver, Lach et 
al. 1993), promyelocytic leukemic HL-60 cells (Bruno, Del Bino et al.
1992), and T-lymphocytes (Sarin, Adams et al. 1993). Several serine 
and cysteine protease inhibitors have been used to investigate the 
involvement of such proteases in apoptosis. Some of these protease 
inhibitors include N-tosyl-L-lysine chloromethane, N-tosyl-L- 
phenylalanine chloromethane, phenylmethylsulfonyl fluoride, and 
dichloro isocoumarin. Inhibition of proteases were required for 
internucleosomal cleavage, cell shrinkage, and plasma membrane 
changes, thus, suggesting that cysteine and/or serine proteases were
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effectors of early apoptotic changes(Weaver, Lach et al. 1993; 
Fearnhead, Rivett et al. 1995).
Proteolysis may be a common event in apoptosis; proteins shown 
to be cleaved during apoptosis include: PARP (Lazebnik, Kaufmann et 
al. 1994), laminin B (Neamati, Fern&ndez et al. 1995), 70-kDa protein 
(Casiola-Rosen, Miller et al. 1994), topoisomerases I and II, histone 
HI (Kaufmann 1989), protein kinase Cbl, cPLa2 (Voelkel-Johnson,
Entingh et al. 1995), fodrin (Martin, O'Brien et al. 1995), and 58-kDa 
protein kinase PITSLRE (Lahti, Xiang et al. 1995).
Survivin, a Mew Cancer Anti-Apoptosis Gene
In addition to bcl-2, a novel class of apoptosis inhibitors 
related to the Baculovirus lap gene has been recently identified in 
human, mouse, and Drosophila melanogaster (Adida, Crotty et al. 1998). 
Recently, a gene, which encodes for a structurally unique IAP 
apoptosis- inhibitor protein, designated survivin, has been identified 
(Ambrosini, Adida et al. 1997); survivin inhibits apoptosis induced by 
interleukin-3 growth factor withdrawal when transfected into B-cells 
(Ambrosini, Adida et al. 1997). Unlike Bcl-2 or other IAP proteins, 
survivin is undetectable in adult tissues but becomes prominently 
expressed in all of the most common human cancers of the lung, colon, 
breast, pancreas, and prostate, and in about 50 % of high-grade non- 
Hodgkin's lymphomas in-vivo (Adida, Crotty et al. 1998). Survivin is 
differentially expressed in embryonic and fetal tissues and is 
believed to contribute to tissue homeostasis and differentiation in a 
manner independent of that of Bcl-2 (Adida, Crotty et al. 1998). 
Aberrations of such developmental process may result in expression of 
survivin in neoplastic cells (Adida, Crotty et al. 1998).
Other Oncogenes Modulating Apoptosis
Other oncogenes modulating apoptosis include 1) genes encoding 
the GTP-binding protein Ras, the kinases Raf and Abl; 2) the cellular
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transcription factors AP-1, Rel, Myc, E2F, Nur 77; and 3) the viral 
proteins latent membrane protein-1 (LMP-1) , Tax, large T-antigen, El 
A/B, and E7.
Signaling molecules
The ras genes encode a family of small guanine-nucleotide- 
binding proteins involved in signal transduction. Mutations which 
activate Ras proteins and give them oncogenic potential result in the 
protein being constitutively present in the GTP-bound, active state 
(Barbacid 1987; Saez, Chan et al. 1994). These same mutations also 
confer to these proteins the ability to inhibit apoptosis. The H-ras 
protein can rescue cells from c-Myc-mediated apoptosis in a serum 
deprived environment(Wyllie, Rose et al. 1987), and overexpression of 
activated ras can inhibit apoptosis in the IL-3-dependent murine 
myeloid cell line H7 after withdrawal of IL-3(Moore, Boswell et al.
1993).
Transcription Factors
Expression of Myc is important for cell proliferation, and it i 
also involved in apoptosis induction. Myc interacts with the 
retinoblastoma protein pRb, and it is able to override pRb-induced 
cell cycle arrest (Green, Mahboubi et al. 1994). In the presence of 
certain growth-promoting cytokines, such as IL-2, cell proliferation 
occurs when Myc expression is induced; overexpression of Myc results 
in uncontrolled cell proliferation (Green, Mahboubi et al. 1994). 
Continued expression of Myc under conditions of growth arrest, as in 
murine myeloid cells and Rat-1 fibroblasts deprived of growth factors 
will induce apoptosis in a p53-dependent manner (Askew, Ashmun et al. 
1991; Evan, Wyllie et al. 1992; Hemerking and Eick 1994) since c-Myc 
is a transcription factor of p53 (Reisman, Elkind et al. 1993). 
Induction of apoptosis, however, is dependent on the association of 
Myc with Max (Green, Mahboubi et al. 1994), and it is suppressed by 
Bcl-2 (Bissonnette, Echeverri et al. 1992; Fanidi, Harrington et al.
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1992). Expression of Myc is not required for all forms of apoptosis 
such as that induced by glucocorticoids and transforming growth 
factor-p (Warner, Ludlow et al. 1991; Shi, Glynn et al. 1992). Thus, 
myc can not be considered the ultimate death gene since the cellular 
decision to proliferate or die in response to myc overexpression seems 
to be influenced by other signal stimuli.
Cell surface immunoglobulin-mediated apoptosis of the B-cell 
line WEHI231 involves regulation of the c-myc expression by both Rel 
and NFkB, which have binding sites in the myc promoter (Lee and 
Bernstein 1995a). The Rel family of protooncogenes, which includes 
the transcription factor NFkB, functions both to promote and to 
inhibit apoptosis (Huguet, Enrietto et al. 1994). The effects of rel 
overexpression are cell-type specific, and the overexpression of c-rel 
and v-rel have different effects in the same cell type.
Overexpression of c-rel in primary avian fibroblasts leads to 
transformation, but c-rel overexpression in bone marrow cells leads to 
apoptosis; and v-rel expression in bone marrow cells leads to 
transformation(Huguet, Enrietto et al. 1994). In addition, v-rel also 
blocks apoptosis in chicken spleen cells by preventing degradation of 
the Rel inhibitor protein IkB(White, Roy et al. 1995).
Myb protein also transactivates Myc (Cogswell, Cogswell et al.
1993). Myb expression is highest in hematopoietic cells, and its 
downregulation leads to inhibition of proliferation; in neuroblastoma 
cells its downregulation also leads to apoptosis(Piacentini, Raschella 
et al. 1994b). The expression of c-myb oncogene increases after 
induction of apoptosis in IL-2-dependent cells after growth factor 
withdrawal (Cheng, Liu et al. 1995). As for Myc, Myb-induced 
apoptosis is, at least, cell type specific and dependent on the 
presence of other signal stimuli.
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The AP-1 transcription factor is formed by the expression of the 
protooncogenes encoding Fos and Jun; their expression is rapidly and 
transiently induced by IL-2 and IL-6-dependent mouse myeloma cell 
lines after induction of apoptosis by growth factor deprivation 
(Colotta, Polentarutti et al. 1992). It was suggested that fos and 
jun have an active role in the onset of apoptosis. After treatment of 
mouse myeloma cell lines with antisense oligonucleotide against fos 
and jun, either alone or in combination, the cells were protected 
against apoptosis (Colotta, Polentarutti et al. 1992).
A functional link was established between fos-transformed cells 
and apoptosis by the observation that a large portion of fos- 
transformed rat fibroblasts died through apoptosis after growth factor 
deprivation. Non-transformed rat fibroblasts did not die (Smeyne, 
Vendrell et al. 1993).
Activation of AP-1 is also related to the massive apoptosis that 
occurs in mammary gland epithelium during post-lactation 
involution(Marti, Jehn et al. 1994). Such involution-related 
apoptosis can occur in a p53-dependent or independent manner; a p53- 
independent pathway may be influenced by the levels of Epidermal 
Growth Factor (EGF) and insulin(Merlo, Basolo et al. 1995).
Another transcription factor, E2F (Zhu, Enders et al. 1995), is 
known to modulate apoptosis through its interaction with pRb, a 105- 
kDa phosphoprotein known to act as a cell regulator (DeCaprio, Ludlow 
et al. 1989). The transcription factor E2F interacts with the 
hypophosphorylated form of pRb at the G0/Gi phase (DeCaprio, Ludlow et 
al. 1989), which is believed to be active during growth suppression. 
This transcription factor, E2F, is required for transcription of cell 
genes that participate in growth control and DNA synthesis, such as c- 
myc, c-myb, cdc2, thymidine kinase, dehydrofolate reductase, and DNA 
polymerase-a (Nevins 1992). Overexpression of E2F drives quiescent
43
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cells into the S phase, prevents cycling cells from exiting the cell 
cycle, transforms rat embryo fibroblasts, and ultimately leads to 
apoptosis(Kowalik, DeGregori et al. 1995). Recent data suggested that 
coexpression of c-myc and Tumor Necrosis Factor (TNF) a leads to a 
selective growth advantage for hepatic pre-neoplastic cells by 
disruption of the E2F/pRb pathway and by Transforming Growth Factor 
(TGF) a-mediated reduction in apoptosis (Santoni-Rugiu, Jensen et al. 
1998).
A nuclear steroid hormone receptor transcription factor that is 
required for apoptosis is Nur77, since it can suppress the expression 
of downstream genes involved in such process(Liu, Smith et al. 1994). 
In order for apoptosis to occur, Nur77 must first bind to DNA 
(Yazdanbakhsh, Choi et al. 1995). Other Nur77 family members, with a 
similar DNA binding sequence, have been identified; these include 
human protein TINUR, which also has been shown to be induced during 
apoptosis (Okabe, Takayanagi et al. 1995), a neuronal protein NOR-1 
(Ohkura, Hijikuro et al. 1994), and the human protein TR3, which 
contains a novel enhancer element in the promoter region that may be 
important in the regulation of apoptosis (Uemura, Mizokami et al.
1995).
Therefore, the general pattern emerging from oncogenic 
transcription factor modulation of apoptosis is one in which 
overexpression of factors may induce an apoptotic response. The 
ultimate effect of these factors, whether oncogenic or apoptotic, is 
linked through overlapping patterns of protein transactivation 
produced. The following are some examples that reiterate this 
transactivation: 1) E2F regulates the expression of myb and myc(Nevins 
1992); 2) Myb and AP-1 regulate the expression of myc(Cogswell,
Cogswell et al. 1993); 3) Fas-receptor gene, which is upregulated
following T-cell activation, has been found to have both a Myb 
consensus sequence (Cheng, Liu et al. 1995) and an AP-1 consensus
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sequence in its promoter (Emlen, Niebur et al. 1994). One may ask 
then, does this interaction between Myb and AP-1 with the Fas receptor 
promoter result in increased Fas receptor expression?; 4) E2F and Myc 
interact with pRb(DeCaprio, Ludlow et al. 1989; Zhu, Enders et al. 
1995); 5) overexpression of Myb and Rel can either induce or suppress
apoptosis depending on cell type and even within the same cell type 
under different stimuli or conditions(Huguet, Enrietto et al. 1994; 
Cheng, Liu et al. 1995); and 6) Myb protein also transactivates Myc 
(Cogswell, Cogswell et al. 1993). All of the above examples suggest 
that the cellular response to transcription factor overexpression 
depends on other signals, which are cell-type specific and, perhaps, 
cell-cycle-dependent (Hale, Smith et al. 1996).
Viral Oncoproteins
The Epstein-Barr virus latent membrane protein 1 (LMP-1), 
involved in the transformation of EBV-infected B-cells and epithelium, 
also protects the cells from apoptosis (Henderson, Rowe et al. 1991). 
LMP-1 inhibits apoptosis in B-cells by inhibiting bcl-2 (Henderson, 
Rowe et al. 1991), but not in epithelial cells (Dawson, Eliopoulos et 
al. 1995); for example, when LMP-1 is genetically introduced in 
gastric carcinoma cells, it modulates their malignant potential 
possibly by enhancing apoptosis (Sheu, Chen et al. 1998). LMP-1 also 
induces expression of A20, an apoptosis-suppressor gene, in B-cells 
following stimulation of the CD40 receptor (Tewari, Wolf et al.
1995c).
Tax, a viral oncoprotein of the human T-cell leukemia virus 1 
(HTLV-1), seems to have both apoptotic inducing and suppressing 
capabilities. Tax expression leads to activation of the NFkB-like 
factors, induction of myc expression, and upregulation of A20 
(Laherty, Perkins et al. 1993). Overexpression of tax in Jurkat cell 
leads to apoptosis, the level of which dependents on the duration of
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tax stimulation; apoptosis resulting from a short-term exposure to tax 
stimulation is dependent on prior T-cell activation, while apoptosis 
resulting from long-term exposure to tax stimulation is T-cell 
activation-independent (Chlichlia, Moldenhauer et al. 1995). These 
observations support the idea that tax may function to inhibit 
apoptosis through modulation of the CD28-CD3/TCR co-stimulatory 
pathways(Schwartz 1992).
Tumor Suppressors and Apoptosis 
Properties of Wild-Type p53
The term p53 originally referred to a 53-kilodalton 
phosphoprotein, the product of a 20-kilobase gene on the short arm of 
human chromosome 17 (Harris 1996; Sidransky and Hollstein 1996).
Normal (wild-type) p53 suppresses out growth of genetically damaged 
cells in two ways: by causing a pause in the cell cycle, and by 
promoting exit from the cell cycle altogether through apoptosis 
(Murnane 1995; Harris 1996; Sidransky and Hollstein 1996)] . Its 
inactivation represents the most common genetic lesion in human 
cancers (Hollstein, Sidransky et al. 1991). In 1992, the p53-null 
mice was developed(Donehower, Harvey et al. 1992). The p53 protein 
possess features of a transcription factor (Levine, Momand et al.
1991); and it may act either as an activator of transcription when 
bound to DNA directly, or it may repress transcription when associated 
with a promoter region via the TATA binding protein (Horikoshi, Usheva 
et al. 1995). The C-terminal region of the p53 protein is required 
for sequence specific DNA binding, and the N-terminal region has a 
potent transactivation domain (Zambetti and Levine 1993) . p53
activation promotes differentiation and apoptosis in myeloid leukemia 
cells (Yonish-Rouach, Resnitzky et al. 1991). p53 can also function
as a cell cycle regulator that can induce cell cycle arrest following 
DNA damage (Kastan, Onyekwere et al. 1991) .
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Call Cycle Arrest and Induction of Apoptosis by pS3 in Response
to DMA Damage
Ionizing radiation can result in transient arrest of mammalian 
cells at the Gi and G2 phases of the cell cycle (Kuerbitz, Plunkett et 
al. 1992; Murnane 1995) and in apoptosis (Cohen, Duke et al. 1992; 
Liebermann, Hoffman et al. 1995; Levine 1997). The level of 
intracellular p53 protein rises following exposure to ionizing 
radiation resulting in cell cycle arrest at the Gi phase (Kuerbitz, 
Plunkett et al. 1992). The observation that cells with mutant p53 
genes arrest in G2 suggested a role for p53 as a GI cell cycle control 
checkpoint (Kuerbitz, Plunkett et al. 1992). This checkpoint allows 
time for the cell to repair its DNA damage or to commit apoptosis if 
the damage is severe (Lane 1992), thus, preventing propagation of 
extensive DNA damage to daughter cells and stopping potential 
progression to cancer, hence, the name "guardian of the genome" (Lane
1992).
In normal cells, DNA strand breaks appear to be the necessary 
signal for induction of a p53-mediated apoptotic response since other 
forms of DNA damage, such as that produced by alkylating agents, like 
ethyl methanesulfonate or EMS, do not result in the accumulation of 
p53 (Lee and Bernstein 1993).
Protein inhibitors, such as cycloheximide, abrogate the 
accumulation of p53 following ionizing radiation, and the DNA damage- 
induced-increase in the level of p53 appears to be due to a post- 
transcriptional stabilization mechanism(Kastan, Onyekwere et al.
1991).
Patients with ataxia telangiectasia, a genetic disorder which 
predispose these patients to cancer, have a defect in the induction of 
p53 in response to DNA damage caused by ionizing radiation(Kastan,
Zhan et al. 1992). The induction of p53 following ionizing radiation 
probably requires gene products, which are either missing or defective
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in such disease, that may function upstream of p53 signal transduction 
pathway (Hale, Smith et al. 1996).
The role of p53 as a transcription factor may be the mechanism 
by which p53 leads to Gi arrest following DNA damage. The radiation- 
induced increased levels of p53 leads to upregulation of several 
proteins, including p21WAF1/CIP1, GADD45, and MDM2 (Canman and Kastan 
1995).
The p2iwflF1/CIP1 protein is a downstream effector in p53-dependent Gx 
checkpoint, which acts as a potent inhibitor of cyclin dependent 
kinases that govern the cell cycle, resulting in cell cycle arrest at 
the Gi/S phase (el-Deiry, Harper et al. 1994), a critical checkpoint. 
The p2iMAF1/CIP1 may also interfere with DNA synthesis directly by binding 
to proliferating cell nuclear antigen (PCNA) (Flores-Rozas, Kelman et 
al. 1994; Waga, Hannon et al. 1994), an essential factor in DNA 
replication. Other mechanisms independent of p53-transactivation can 
also elevate the levels of p2lWAF1/CIP1 (Parker, Eichele et al. 1995) . 
Induction of GADD45 (growth arrest DNA damage) is believed to be 
important in suppression of cell cycle progression, a process 
dependent on normal p53 gene function (Zhan, Bae et al. 1994). Like 
p21WAF1/cpn, GADD45 also binds to PCNA and inhibits DNA synthesis [Smith, 
1994 #269]. The MDM2 expression contributes indirectly to the control 
of the cell cycle through a feedback loop to p53 itself, acting as a 
negative modulator by binding and suppressing its transcriptional 
activity (Chen, Oliner et al. 1994). MDM2 causes downregulation of 
p53-dependent genes with concomitant re-entry into the cell cycle 
presumably after the DNA damage has been repaired.
In addition to cell cycle arrest, a frequent consequence of 
mammalian DNA damage is apoptosis (Cohen, Duke et al. 1992). This 
often, but not always, occurs through a p53-dependent pathway. The 
action may be dependent on the cell itself and the circumstances that 
surrounds it. Immature thymocytes from normal and from p53-null mice
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underwent apoptosis in response to glucocorticoids or to activation 
with phorbol ester and ionomycin (Lowe, Schimitt et al. 1993). In 
contrast to control mice cells, immature thymocytes deficient in p53 
were resistant to apoptosis by ionizing radiation or by the DNA- 
damaging topoisoraerase XI inhibitor, etoposide (Clarke, Purdie et al.
1993). Moreover, thymocytes which only had one wild-type p53 allele 
exhibited intermediate sensitivity to apoptosis induction by ionizing 
radiation when compared to normal thymocytes and to those from p53- 
null mice (Clarke, Purdie et al. 1993), thus, suggesting a p53 dose- 
dependent effect.
Bone marrow cells(Lotem and Sachs 1993) and intestinal 
epithelial cells(Clarke, Gledhill et al. 1994) from p53-null mice were 
resistant to radiation-induced apoptosis when compared to controls; 
however, these cells could also undergo apoptosis in response to 
different stimuli, indicating that p53-dependent and independent 
apoptotic pathways may co-exist.
The presence or absence of growth factors may influence p53- 
mediated Gt arrest or apoptosis. Bone marrow-derived hematopoietic 
cells are resistant to ionizing radiation-induced apoptosis when 
cultured in the presence of growth factors, but arrest in Gi phase 
(Collins, Marvel et al. 1992). When these bone marrow-derived 
hematopoietic cells are cultured without growth factors, apoptosis 
occurs through a p53-dependent pathway(Blandino, Scardigli et al.
1995); this has been found to be accelerated following DNA 
damage(Canman and Kastan 1995). Direct transcriptional regulation of 
bcl-2 family members may also be involved in the induction of 
apoptosis by p53.
Inhibition of Apoptosis by pRb
The functions of the retinoblastoma gene product, pRb, are to 
control cell cycle progression and suppress apoptosis, and, along with 
other pRb-related proteins, play a major role in determining whether
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cells respond to a given stimulus by undergoing growth arrest or 
apoptosis. Mice homozygous for mutant pRb die between days 10-14 of 
gestation, with increased levels of cell division and apoptotic cell 
death in hematopoietic cells and nervous systems(Clarke, Maandag et 
al. 1992). In addition, it has been observed that inappropriate 
apoptosis also occurs in the ocular lens of pRb-null mice 
(Morgenbesser 1994).
SAOS-2 osteosarcoma cells, which are p53 and pRb deficient, were 
protected from radiation-induced apoptosis in a p53-independent 
mechanism after transfection of pRb when compared to non-transfected 
controls (Hass-Kogan, Kogan et al. 1995). In contrast, SAOS-2 
osteosarcoma cells transfected with a mutant form of pRb, one that 
fails to bind to adenovirus E1A protein or the transcription factor 
E2F, are not protected from apoptosis(Hass-Kogan, Kogan et al. 1995). 
One way in which pRb may protect cells from radiation-induced 
apoptosis is by induction of a quiescent state in which the cells are 
less sensitive to apoptosis (Clarke, Maandag et al. 1992).
Interactions of p53 and pRb With Viral Proteins
Several studies indicate that certain viruses encode for 
oncoproteins that bind pRb and p53, and impair their normal function 
to accomplish its replicative strategy. The SV40 large T antigen, the 
adenovirus E1A, and the human papilloma virus (HPV) E7 proteins bind 
to the hypophosphorylated form of pRb and inactivate it (DeCaprio, 
Ludlow et al. 1988; Whyte, Buchkovich et al. 1988; Dyson, Howley et 
al. 1989). Moreover, interaction of E1A and pRb results in apoptosis 
(Rao, Debbas et al. 1992). The sequences from E1A required for pRb 
binding and transformation are the same ones responsible for E1A- 
mediated apoptosis (Hass-Kogan, Kogan et al. 1995). Thus, it is 
likely that blocking of the pRb-mediated cell cycle control at the Gj 
phase may be required to push the infected cell into S phase and 
initiate viral DNA replication.
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The E1A oncoprotein, acting as a transcription factor, competes 
with d 53 for interaction with the same domain of the TATA binding 
domain (TBP) (Horikoshi, Usheva et al. 1995), since p53 inhibits 
transcription when bound to TBP. Part of the E1A's ability to induce 
cell proliferation and bring about apoptosis lies in the ability to 
disassociate p53 from TBP, and activate p53-repressed genes(Horikoshi, 
Usheva et al. 1995). It demonstrated that the adenovirus E1B 19-kDa 
protein, which does not bind to p53, inhibits p53-dependent apoptosis 
mediated by E1A, thus allowing replication of viral genome(Debbas and 
White 1995; Sabbatini, Chiou et al. 1995). The SV40 large T antigen, 
adenovirus E1B 55-kDa protein, and HPV E6 protein target p53 function 
by binding to it either directly or indirectly(Levine 1990). It was 
proposed then that each of these viral proteins bind to p53 at 
different regions inhibiting both of its transcriptional and 
functional properties(Prives and Manfredi 1993). Epstein-Barr virus 
(EBV) exhibits a p53- and pRb-independent mechanisms to drive resting 
B-cells into proliferation without disruption of the cell's ability to 
undergo apoptosis in a p53-dependent manner following damage of their 
DNA (Allday, Sinclair et al. 1995).
The p53 Signaling Pathways
The signaling pathways of p53 connect with tumor both 
suppressors and oncogenes known to influence the cell cycle machinery. 
Alterations in components either upstream or downstream of p53 may be 
analogous to inactivation of p53 itself, preventing all or part of 
the entire pathway from functioning and leading to deregulation of 
cell cycle controls, genomic instability, and the development of 
cancer(Agarwal, Taylor et al. 1998).
The components of the p53 signaling pathway were summarized by 
Agarwal, 1998. p53 accumulates and is modified and activated in
response to signals generated by a variety of genotoxic stresses. 
Several proteins, including ATM, the product of the ataxia
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
telangiectasia gene, PARP (poly(ADP-ribose) polymerase), FAS (Fanconi 
anemia syndrome), BLS (Bloom's syndrome), and NBS (Nijmejen breakage 
syndrome), are involved in activation, but the pathways that lead to 
modification are largely unknown. The Ras-Map kinase pathway is 
involved in establishing basal levels of p53 and may also affect 
function. Some of the cellular functions affected by p53 can be 
compromised by deregulated expression of Myc, Bcl-2, E1B, or E2F. The 
control of p53 activity includes an autoregulatory loop involving 
Mdm2. The intact set of p53-dependent pathways helps to maintain 
genomic integrity by eliminating damaged cells, either by arresting 
them permanently or through apoptosis. p53 also helps to regulate 
entry into mitosis, spindle formation, and centromere integrity, cell 
cycle checkpoints that are likely to be involved in preventing DNA 
damage from occurring (Agarwal, Taylor et al. 1998).
ING1, A New Tumor Suppressor Gene Candidate 
Overexpression of the growth inhibitor and candidate tumor 
suppressor called p33:NG1, like p53, can arrest cells at the G0/G1 phase 
of the cell cycle(Garkavtsev, Kazarov et al. 1996), and it has been 
recently demonstrated that it can also modulate apoptosis in serum- 
starved P19 teratocarcinoma cells and in rodent fibroblast cell lines 
which overexpress human c-myc protein (Helbing, Veillette et al.
1997).
Cellular Consequences of Apoptosis 
Nuclear Changes and DNA Fragmentation
The precise mechanisms by which chromatin condensation and 
nuclear envelope breakdown occur during apoptosis are unknown.
Nuclear laminin are intermediate filaments that associate with the 
inner nuclear membrane. They organize the nucleoskeleton and provide a 
framework for the attachment of chromatin to the nuclear envelope. It 
has been observed that nuclear laminin loses its integrity upon
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phosphorylation by p34cdc2 kinases during the chromatin breakdown that 
occurs in mitosis(Peter, Nakagawa et al. 1990). During apoptosis, 
however, laminin disassembly occurs by proteolysis, which is 
apparently an irreversible event (Kaufmann 198 9). Glucocorticoids 
promote thymocyte laminin B-l degradation (Neamati, Fernandez et al. 
1995). The protein responsible for this glucocorticoid-promoted 
degradation, Lam-P, is distinct from prICE (Earnshaw 1995a). Lamp-1 
binds to a specific DNA sequence motif, called matrix attachment 
regions. These regions are spaced at 20 to 50 kilobase pairs and are 
believed to mediate the interaction of chromatin with the nuclear 
matrix. It has been suggested that nuclear laminin degradation 
promotes formation of large DNA fragments by allowing the release of 
matrix attachment regions and providing access for endonucleases to 
act on the DNA(Neamati, Fernandez et al. 1995).
A biochemical hallmark of apoptosis is the formation of distinct 
oligonucleosomal fragments, usually of 180-200 base pair (bp) length 
that result from the internucleosomal cleavage of DNA. Larger and 
smaller oligonucleosomal fragments have also been reported 
(Oberhammer, Wilson et al. 1993; Solis-Recendez, Perani et al. 1995).
Topoisomerase II is believed to be important in the adherence of 
matrix attachment regions to a chromosomal 50 kb chromatin-loop 
domain. It has been implicated as a nuclease involved in chromatin 
fragmentation (Arends and Wyllie 1991; Sun and Cohen 1994). However,
it was suggested that topoisomerase II does not seem to be involved in
the active formation of 50 kb fragments in HL-60 and MOLT-4
cells(Beere, Chresta et al. 1995).
It is widely believed that DNA cleavage characteristic of 
apoptosis is the result of an endogenous, neutral, Ca2+ and Mg2*- 
dependent endonuclease capable of inducing double strand breaks at 
internucleosomal sites (Arends, Morris et al. 1990); such endonuclease 
is also inhibited by zinc and produces 3'-OH DNA breaks (Earnshaw
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1995b). Several candidates have been recognized: DNase-I (Peitsch,
Polzar et al. 1993); DNase-II (Barry and Eastman 1993); Nuc-18 (Caron- 
Leslie, Schwartzman et al. 1991); Nuc-1 (Yuan 1995); 27-kDa nuclease 
(Ribeiro and Carson 1993); and Nuc-40 and Nuc-58 (Deng and Podack 
1995).
DNase-I has Ca2* and Mg2+-dependent endonuclease activity, with an 
optimum pH of 7.5 (range is 5.5-9.0). It is localized mainly in the 
endoplasmic reticulum and perinuclear Golgi complex. DNase-I is 
specifically inhibited by actin, and antibodies directed against it 
reduce DNA laddering in thymocytes (Polzar, Peitsch et al. 1993). It 
induces morphological and biochemical changes observed during 
apoptosis in transfected COS cells (Polzar, Peitsch et al. 1993) .
DNase-II is located primarily in lysosomes but is also in the 
nucleus. It is Caz+ and Mg2+-independent and requires an acid 
environment for activation, with a pH optimum of 5.5 (range 3.0-7.0). 
DNase-II can cause apoptotic DNA laddering in CHO cells (Barry and 
Eastman 1993). It is probably an unlikely candidate for the apoptotic 
nuclease because it generates 5'-OH DNA fragments, and it is not 
inhibited by zinc, which is known to inhibit DNA fragmentation 
(McGowan, Fernandes et al. 1994). Zinc also inhibits the 
intracellular acidification required for DNase-II activity which may 
be an alternative means by which it inhibits DNA fragmentation 
(Morana, Li et al. 1994).
Nuc-18 was isolated from apoptotic thymocyte nuclei and is 
induced by the glucocorticoid receptor (Caron-Leslie, Schwartzman et 
al. 1991). It is a neutral endonuclease induced by dexamethasone and 
dependent on calcium and magnesium for its activity. Nuc-18 may exist 
in a complex with a repressor protein, which separates from it after 
glucocorticoid treatment. Its nuclear localization and cation 
dependence supports its possible role in apoptosis. Nuc-18 shows
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sequence similarity to cyclophillin A and related proteins for the 
immunosuppressive drug cyclosporin.
Another candidate, the 27-kDa nuclease isolated from human 
spleen cell nuclei (Ribeiro and Carson 1993), has a pH optimum of 8.0, 
is Ca2+/Mg2‘-dependent, and zinc inhibits its activity. This nuclease 
is able to produce mono- and oligonucleosomal DNA fragmentation 
characteristic of apoptosis. Nuc-40 and Nuc-58 were identified from 
the extract of IL-2-depndent CTLL2 cells (Deng and Podack 1995).
Nuc-58 has Ca2+/Mg2+-dependent activity and is found primarily in the 
cytosol. Nuc-40 is mainly a nuclear nuclease with a Mg2+-dependent 
activity. Nuc-1 is associated with, but not essential for, DNA 
fragmentation and cell death in Caenorhabditis elegans . Nuc-1 is 
also expressed by the engulfing cell, rather than by the dying cell 
itself (Yuan 1995).
Cytoplasmic Changes in Apoptosis
The main feature of the cytoplasmic changes that occur in 
apoptosis is the formation of apoptotic bodies after shrinkage and 
fragmentation of the cell. Such event probably occurs due to 
rearrangement of the microfilament network of the cell. The 
microtubule-disrupting agents, colchicine and vinblastine, as well as 
noconazole were used to induce apoptosis in HL-60 cells, and it was 
suggested that disruption of the microtubule network initiates a 
series of events that lead to apoptosis(Martin and Cotter 1990). 
Tissue-type or type II transglutaminase are cytosolic proteins of 
80-kDa that accumulate selectively in cells undergoing apoptosis 
(Piacentini, Davies et al. 1994a). Transglutaminases belong to a 
family of Ca2‘-dependent glutamine and glutamyl transferases 
(Piacentini, Davies et al. 1994a). Five transglutaminases have been 
identified in humans (Greenberg, Birckbichler et al. 1991): 1) tissue
transglutaminase (TGase 2), 2) blood coagulation factor XIII, 3)
TGase 4, 4) keratinocyte transglutaminase (TGase 1), and 5) epidermal
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transglutaminase (TGase 3). These transglutaminases appear to have 
different functions, but all are important in the protection of cell 
and tissue integrity. The mRNA levels of tissue transglutaminase 
(TGase 2) are highly elevated at the onset of apoptosis along with 
cytosolic calcium, which is needed for enzyme activation (Piacentini, 
Davies et al. 1994a). Crosslinking of intracellular proteins 
stabilizes the cytoplasm of dying cells, thus, preventing leakage of 
intracellular elements into the extracellular environment. 
Immunological characterization of the crosslinked matrix indicate that 
it is composed of actin, annexin-II, vinculin, fibronectin, and others 
(Knight, Hand et al. 1993).
Call Membrane Alterations in Apoptosis
There are extensive cell membrane alterations that occur in 
apoptosis. There is detachment from neighboring cells, from the 
culture substrate in-vitro or from the extracellular matrix in-vivo. 
Specialized structures, like microvilli, are lost as well. Cell 
surface markers, like the avba vitronectin receptor, CD36, and 
thrombospondin, as well as changes in membrane sugars and lipid 
composition are important in assuring swift recognition by phagocytic 
cells (Savill, Fadock et al. 1993; Savill 1995) avoiding leakage of 
cellular contents into the extracellular environment, thus, avoiding 
an inflammatory response and subsequent tissue damage.
A variety of cells, in addition to resident tissue macrophages, 
may participate in the removal of apoptotic bodies through 
phagocytosis, and are sometimes referred to as "non-professional 
macrophages". The observation that phagocytosis of apoptotic bodies 
was inhibited by peptides and proteins containing an arginine-glycine- 
aspartic acid (RGD) sequence (Savill, Dransfield et al. 1990), first 
implicated integrins in the recognition of apoptotic neutrophils by 
macrophages.
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A change in the lipid composition of the plasma membrane allows 
recognition of apoptotic cell by phagocytes. Normally anionic 
phosphatidylserine is found in the inner plasma membrane, while 
neutral phospholipids sphingomyelin and phosphatidylcholine are on the 
outer membrane bilayer. During apoptosis phosphatidylserine is 
exposed on the outer membrane surface, which appears to be important 
in eliciting a phagocytic response (Fadock, Voelker et al. 1992). 
Lipocortin-1, which is upregulated in apoptotic cells occurring in 
mammary regression, binds to calcium ions and phosphatidylserine, and 
is implicated in the phosphatidylserine-elicited phagocytosis (McKanna 
1995). Apoptotic cells also bind to annexin-V, a calcium-dependent 
phospholipid binding protein with high affinity for phosphatidylserine 
(Homburg, de Hass et al. 1995).
The reduced anionic charge that apoptotic cells have implies 
loss of terminal sialic residues, which may unmask other sugar 
residues, such as N-acetylglucosamine and N-acetylgalactosamine, and 
could interact with a phagocytic recognition lectin on the macrophage 
surface (Duval, Wyllie et al. 1985). A role for other receptors, such 
as the CD16 (FcyRIII) (Dransfield, Buckle et al. 1994), in the 
recognition of apoptosis has been suggested.
In the nematode Caencrhabditis elegans there are seven genes 
downstream of the ced-3 and ced-4 control point involved with the 
process of phagocytosis of dying cells (Ellis, Jacobson et al. 1991), 
the existence of which suggest that several different mechanisms may 
be employed in the elimination of apoptotic bodies in mammalian 
tissues.
Because apoptosis is associated with cell surface membrane 
alterations, it has been suggested that there is an association 
between apoptosis and cell surface tissue factor procoagulant 
activity(Greeno, Bach et al. 1996). Such an association may help to
57
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regulate the flux of cells into tissues being remodeled by apoptosis 
since there is a linkage between the coagulation system with wound 
healing and neoplasia (Greeno, Bach et al. 1996) .
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CHAPTER 2. IMMUNOHISTOCHEMICAL DETECTION OF APOPTOSIS IN THE LIVER
OF FUNDULUS GRANPIS AFTER EXPOSURE TO N-METHYL-N * -NITRO-N- 
NITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
Apoptosis is now accepted as a critical element in the 
repertoire of cellular responses, but there is still an incomplete 
picture of the multiple features and complex intracellular processes 
involved. In multicellular organisms homeostasis is maintained 
through a balance between cell proliferation and cell death. 
Dysfunction in the maintenance of this balance is believed to be 
important in the pathogenesis of neoplasia. This makes the study of 
apoptosis an active area of research in today's multidisciplinary 
biological sciences.
Although fish have become a popular model for cancer studies, 
only a few published articles have referred to the process of 
apoptosis in fish (Soutscheck and Zupanc 1996; Bjoerklund, Johansson 
et al. 1997) and only one article has related apoptosis to 
preneoplastic hepatic lesions in the English Sole model (Malins, 
Polissar et al. 1996).
In order to examine the balance between cell proliferation and 
cell death in the livers of fish exposed to the alkylating agent, n- 
methyl-n'-nitro-n-nitrosoguanidine (MNNG), or to the polycyclic 
aromatic hydrocarbon, 2-aminofluorene (2-AF), apoptosis was evaluated 
by immunohistochemical (IHC) detection methods. To perfect 
methodology for these IHC techniques in fish, several preliminary 
studies were required, however.
The studies reported here include (1) a study to determine the 
stability of MNNG in saltwater, as required in our fish model, (2) the 
suitability of different fixatives, on IHC identification in fish 
tissues, and (3) finally, the determination of apoptotic frequencies 
in livers of fish subjected to short and long term exposures.
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Materials and Methods 
Experimental Design
To determine the stability of MNNG in saltwater to which fish 
would be exposed over a time course in later experiments, the compound 
was added at a concentration of 34 pM to 5 parts per thousand (ppt) 
saltwater, and the solution was sequentially analyzed by high- 
performance liquid chromatography (HPLC).
Livers from fish exposed to MNNG were fixed in 1 of 3 different 
fixatives; buffered 10 % formalin, methacarn, or Strek's fixative. 
Livers were then processed by routine techniques and subjected to IHC 
staining techniques to identify apoptotic events. The overall tissue 
morphology and clarity and specificity of staining characteristics 
were subjectively compared to determine the most suitable fixative for 
use in later experiments.
Finally, groups of fish were exposed to MNNG or 2-AF at two 
different time durations and at two different concentrations, and 
apoptotic activity was quantitatively determined.
Fish and Housing
For this study Fundulus grandis fish was chosen as a model for 
chemically-induced liver cell injury because it lives in brackish 
waters along the Gulf coast of the southeastern United States, where 
the Mississippi river meets the Gulf of Mexico. This fish serves as 
an environmentally sensitive species for aquatic pollution in this 
region. This fish is well adapted to laboratory conditions, and it 
has been used previously as a model for studies of chemical 
carcinogenesis (Hawkins, Overstreet et al. 1988).
For the initial experiments, three groups of 32 Fundulus grandis 
juvenile fish each were kept in separate aquarium tanks, each 
containing 30 L of 5 ppt saltwater, pH 8.4, and maintained between 26
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to 28°C. Fish tanks were kept within a laminar flow hood during the 
duration of the experiment.
For the long term experiments, three groups of 300 Fundulus 
grandis juvenile fish each were kept in separate aquarium tanks, each 
containing 540 L of 5 ppt saltwater, pH 8.4, and maintained between 26 
to 28° C in a recirculation system (see figure 2.1). Fish from group 1 
were treated as control fish and were kept in a separate room from 
exposed fish in groups 2 and 3; these were kept in a high-hazard, 




•: S W  —
Si od
Figure 2.1. Sample Diagram of the Recirculation System Used. 
Arrows indicate the water flow direction.
Rationale for Using the Liver as the Target Organ
In teleost fish and mammals the liver serves as the major site 
of deactivation or detoxification of some xenobiotics as well as a 
site for activation of other compounds into their toxic (active) form 
by the cytochrome P450-mediated, mixed function oxidase system. 
Toxicologic pathology of the liver has been reviewed in both mammalian 
(Arias, Jakoby et al. 1988) and teleost fish species (Hinton, Teh et 
al. 1992).
Compounds Usod
The direct acting alkylating agent, n-methyl-n’-nitro-n- 
nitrosoguanidine (MNNG), belongs to the N-nitroso group of chemical
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agents, which includes the N-nitrosamides, N-nitrosamines, and others. 
As reviewed by Margison and O'Connor (Margison and O'Connor 1979), 
compounds belonging to this group are known to be carcinogenic in many 
animal species and for a variety of different tissues; these compounds 
are teratogenic and mutagenic and can have an effect on the synthesis 
of DNA, RNA, and proteins. The chemical MNNG has been used freguently 
in fish to induce neoplasia in liver and other tissues (Hawkins, 
Overstreet et al. 1988; Bunton 1994; Bunton and Wolfe 1996).
The genetic toxicity of the polycyclic aromatic hydrocarbon 2- 
aminofluorene (2-AF) has been recently reviewed (Heflich and Neft 
1994). The compound 2-AF, along with the compound 2- 
acetylaminofluorene, are among the most intensely studied of all 
chemicals and mutagens. Research concerns are centered on the 
metabolism of 2-AF and the interaction of the metabolites with DNA and 
the carcinogenic and mutagenic responses that are associated with the 
resulting DNA damage (Widlack, Widlack et al. 1993; Heflich and Neft 
1994). The levels of hemoglobin adduct and hepatic- and urinary 
bladder-DNA adduct levels in Syrian hamsters administered 2-AF has 
also been studied (Flammang, Yerukon et al. 1992) .
Dosing Rationale and Route of Administration
The dosing of the compounds used, MNNG and 2-AF, was based on a 
parts per million (ppm) basis since most of the published literature 
has used this conventional method for reporting concentration of a 
chemical compound. The concentrations used in these experiments were 
calculated and reported on a molar basis for each of the compounds.
The dose used for MNNG was based in the lowest published concentration 
for MNNG-induced neoplasia in fish, which is 1 ppm or 6.7 pM (Bunton 
and Wolfe 1996; Couch and Harshbarger 1985) . Initially, an equimolar 
concentration of MNNG and 2-AF was considered, but because of the poor 
solubility of 2-AF, route of exposure (feed), amount of feed consumed
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daily by the fish, and the assurance of a well distribution of the 
compound in the feed, a higher dose was chosen, which consisted of 
6.9 mM 2-AF.
The route of administration chosen for MNNG was that of an 
aqueous medium because of its higher solubility in water which was 
aided by using dimethyl sulfoxide (DMSO) as a solvent. Because of the 
poor solubility of 2-AF in water, the route of administration chosen 
for this compound was in the feed. Appendix 2.A shows general 
chemical data for both of these compounds.
Determination of MNNG Stability in Saltwater
A 100 pi sample from a 34 pM MNNG solution in distilled water 
(pH = 7.01) was injected into the HPLC machine to establish baseline 
Ultra-Violet (UV) light spectrum. This was followed first by a 100 pi 
injection of 5 ppt saltwater alone, then by a 100 pi 34 pM MNNG 
solution in 5 ppt saltwater (pH = 8.56) into the HPLC instrument. The 
results were read immediately after injection, then every 10 minutes 
thereafter for a total of 60 minutes. Time 0 represents the time of 
actual mixing and preparation of the solution. Solvents used were 
HPLC-grade acetonitrile and distilled water.
Preparation of Feed Containing 2-AF
To prepare a feed mix containing 6.9 mM 2-AF to be fed ad- 
libitum for 5 consecutive days, several parameters had to be 
determined. First, the average consumption of feed in a dry matter 
basis was estimated to be at least at 2 % of the body weight (NRC 
1986) . For all groups, the average body weight of fish sampled at 
day 0 of the experiment was 3.0 g/fish. The total estimated five-day 
feed consumption for the 300 fish in the 2-AF exposed group was 0.1kg.
Molarity was calculated as grams of 2-aminofluorene/ molecular 
weight of 2-aminofluorene (M.W.= 181.24) in 1 kg of feed (see appendix 
2.A for general chemical data on 2-AF). For a 6.9 mM 2-AF feed mix,
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0.126 g of the compound were mixed with 0.1 kg of grounded feed after 
diluting with 5 ml of 100 % ethyl alcohol. The mixture was placed 
overnight on a mechanical roller to assure a good distribution. Based 
on an average daily feed consumption of 2 % of the body weight, it was 
estimated that each fish consumed at least 0.06 g of the feed mixture 
per day or 7.56 x 10'fi g 2-AF/day.
Effect of Three Types of Fixative on ZCH Detection of Apoptosis
in Livers
Fish from each tank were exposed to 6.7 pM of MNNG saltwater 
solution once daily for three consecutive days. Groups of 4 fish were 
sampled from each tank at days 0, 1, 2, 3, 6, 9, 12, and 15. Fish 
were euthanized by immersion in 0.4 % tricaine methanesulfonate 
solution. The coelomic cavity was injected with one of three 
fixatives, methacarn, Strek Tissue Fixative (S.T.F., Strek's 
Laboratories, Nebraska), and buffered 10 % formalin. The body was 
immersed in the respective fixative at a ratio of 1 : 20. Whole-fish 
specimens were processed and embedded in paraffin blocks. Tissue 
sections from each specimen were stained with hematoxylin and eosin 
and evaluated histologically. From each of the sampling days ( 0, 1, 
2, 3, 6, 9, 12, and 15), a fish specimen was randomly selected from 
each of the three fixative groups, for a total of 24 fish specimens, 
for immunohistochemical detection of apoptosis.
Immunohistochemical Detection o£ Apoptosis in Liver of Fish
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
Fish from group 1 were treated as control fish and received no 
treatment. Fish in group 2 were exposed to 6.7 pM n-methyl-n'-nitro- 
n-nitrosoguanidine (MNNG) solution one time, at day 0 of the 
experiment, and remained within this tank for the rest of the 
experiment. Fish in group 3 were fed ad-libitum for five consecutive 
days feed containing 6.9 mM of 2-aminofluorene (2-AF). Twenty five 
fish were sampled from each group at days 0, 3, 9, 21, 45, 90, and 180
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days of the experiment. The total body weight of each 25-fish sample 
was recorded. Fish were euthanized by immersion in 0.4 % tricaine 
methanesulfonate solution. The liver was dissected from each fish and 
submerged immediately in buffered 10 % formalin fixative solution; 
the head was hemisected and placed in buffered 10 % formalin fixative 
solution containing formic acid, a decalcifying agent. The specimens 
were left in fixative solution for 8 to 12 hours, then processed and 
embedded in paraffin blocks. Ten of the 25 fish specimens sampled 
from each group were randomly selected for immunohistochemical 
detection of apoptosis. All 25 specimens sampled from each group were 
stained with hematoxylin and eosin and evaluated histologically.
Inamnohistochamiol Technique for Identifying Apoptosis 
in Tissues
The procedures described for the In-Situ Cell Death Detection 
Kit, Peroxidase (POD) (Boehringer-Mannheim, Indiana) for 
immunohistochemical detection of apoptosis in tissue sections were 
followed according to the manufacturer, with few modifications.
Briefly, after the sections were deparaffinized and rehydrated to 
distilled water, the slides were incubated with 0.4 % pepsin solution 
in 0.01 N HC1 for 10 minutes at 37° C. Endogenous peroxidase was 
blocked with 0.3 % H20= in methanol for 45 minutes, and the tissue 
sections permeabilized with 0.1 % Triton X-100 in 0.1 % sodium citrate 
for 2 minutes on ice. The tissue DNA strand breaks were fluorescein- 
labeled by adding 50 |il of terminal deoxynucleotidyl transferase- 
mediated dUTP nick end-labeling (TUNEL) reaction mixture on the tissue 
sample, and incubated in a humidified chamber for 60 minutes at 37° C. 
To the tissue samples, 50 jxl of Converter-POD, which contained anti­
fluorescein antibody Fab fragment from sheep conjugated with 
horseradish peroxidase, were added on for signal conversion. The 
slides were incubated in a humidified chamber for 30 to 60 minutes at 
37° C. The chromogen, diaminobenzidine, was utilized. The slides were
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counterstained with Mayer's hematoxylin, dehydrated, cleared, and 
mounted on a resinous media. For negative controls, fixed and 
permeabilized tissue slides were incubated in 50 pi Label Solution 
(without terminal transferase) instead of TUNEL reaction mixture. For 
positive controls, fixed and permeabilized tissue slides were 
incubated with DNase 1 (l|ig/ml, 10 minutes at room temperature to 
induce DNA strand breaks) (Fehsel, Kolb-Bachofen et al. 1991;
Gavrieli, Sherman et al. 1992).
Cytometry
Using a squared (grid) graticule, the total number of 
diaminobenzidine (DAB)-stained, positive liver cell nuclei was 
recorded from a total of five randomly chosen fields counted at 40-X. 
The average was recorded and divided by a conversion factor of 0.03132 
mm2, which was obtained after calibrating the graticule for the 40-X 
microscope objective lens. The data was reported as number of 
positive cell nuclei/mm2 of liver tissue. The criteria described by 
Gavrieli et al., 1992, for identifying positive-stained apoptotic 
cells were used. The type of cells counted included mainly 
hepatocytes, but also biliary epithelial cells, endothelial cells, and 
pancreatic epithelial cells were included in the counts.
Statistical Analysis
A regression analysis was done on the data obtained from the 
HPLC machine to predict degradation time estimates for MNNG. Two- 
factor factorial analysis of variance for the data obtained from the 
immunohistochemical detection of apoptosis was performed using the 
following statistical model: Yijk is N {|iij,cr2}, assume all observations
independent and equal variances; where i represents group- control, 
MNNG, 2-AF; j represents days- 0, 3, 9, 21, 45, 90, 180; and k
represents counts- 1 through 210. Values were considered significant 
if the value of P was equal to or less than 0.005. All of the
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statistical data analysis was performed using a Statistical Analysis 
System (SAS) computerized program.
Results 
MNNG Stability in Saltwater
High-performance liquid chromatography analysis detected three 
peaks at different intervals during the first 7 to 8 minutes post 
injection of the 34 pM MNNG saltwater solution (see figure 2.2).
Their retention time and area under the curve from each peak were 
measured (see table 2.1). The first two peaks were noted in both the 
5 ppt saltwater solution and in the 34 pM MNNG plus 5ppt saltwater 
solution. The third peak was interpreted to correspond to that of 
MNNG. A histogram chart of area vs time (see histogram 2.1) and a 
regression analysis were performed for peak number three (see appendix 
B), which shows that a 34 pM MNNG solution in 5 ppt saltwater was 
degraded by 70 minutes after its preparation.
Effect of Fixative on IHC Detection of Apoptosis in MNNG 
Exposed Fish Livers
Of the three fixatives, methacarn, Strek's, and buffered 10 % 
formalin, the best all-around fixation was provided by the formalin 
solution. The fixation was subjectively evaluated on preservation of 
overall cellular and tissue morphology, retention of nuclei, lack of 
tissue structural distortion, and differential staining 
characteristics. Most of the lesions in these livers were few and of 
mild degree (see table 2.2). Vacuolar and hyperplastic changes were 
mild in most fish. The most severe changes were found in three fish 
livers and occurred at days 1, 2, and 12. Day 1: There were
scattered hypercellular foci of hepatocytes. Individual hepatocytes 
occurred in a tubulo-sinusoidal arrangement. These had a 
hyperchromatic, round to oval nuclei, with moderate anisokaryosis. 
Mitotic figures and apoptosis varied from 0-2 per hpf. Multinucleated
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Figure 2.2. Representative HPLC Peaks Obtained After Injection 
of 34 (iM MNNG Saltwater Solution
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Table 2.1. Data Summary of the HPLC Peaks, Retention Times, and Area 
Under the Curve for 34 pM MNNG in 5ppt salt water
MNNG 5PPM IN SALT WATER






2 1 10 1.587 371.41
3 1 20 1.567 205.91
4 1 30 1.561 277.46
5 1 40 1.546 329.18
6 1 50 1.545 352.77
7 1 60 1.532 391.13
8 1 70 . ,
9 1 80
10 1 90 ,
11 2 0 .
12 2 10 2.502 241.80
13 2 20 2.519 38.01
14 2 30 2.522 36.97
15 2 40 2.511 37.92
16 2 50 2.524 38.17
17 2 60 2.510 39.14
18 2 70 •
19 2 80 .
20 2 90 . .
21 3 0 . .
22 3 10 7.164 729.92
23 3 20 6.761 494.89
24 3 30 6.240 371.66
25 3 40 6.096 271.38
26 3 50 5.840 201.87
27 3 60 5.584 159.62
28 3 70 . .
29 3 80 . .
30 3 90 . ,
*Area in electronic integrator area counts (unitless)
cells occurred occasionally. The cytoplasm was eosinophilic with 
increased numbers of small, clear vacuoles. In addition, there were 
few admixtures of mononuclear inflammatory cells, which were seen in 
scattered areas. Day 2: There were widespread areas of hepatocytic
hypercellularity with scattered admixtures of lymphocytes, plasma 
cells, and histiocytes. Individual hepatocytes had similar nuclear 
features as those described on day 1. Occasional multinucleated 
hepatocytes were also found. Increased number of intracytoplasmic
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Histogram 2.1. Degradation of 34 MNNG in 
5 ppt Saltwater : Peak No. 3
800
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clear vacuoles were also noted; the cytoplasm was more basophilic. In 
addition, scattered individual hepatocytic apoptosis occurred at 0-1 
per hpf. Day 12: There were multiple, distinct foci of hepatocytic 
hypercellularity. Individual cells had mild nuclear pleomorphism, 
with a densely eosinophilic cytoplasm, and a few clear 
intracytoplasmic vacuoles. Apoptosis occurred at 1-2 per hpf, 
especially in areas associated with mild admixtures of mononuclear 
inflammatory cells, most of which are noted primarily in perivascular 
spaces. In addition to the changes described above, in other fish, 
inflammation of the liver was the main histological feature observed. 
This varied from mild to moderate to severe, and it was recognized 
throughout the experiment. The predominant cell types were a mixture 
of lymphocytes, eosinophilic granular cells, and fewer macrophages.
Granulomas also occurred throughout the experiment; these were 
characterized by distinct, well demarcated collections of epithelioid 
macrophages with degenerated, brown/gold pigment in the center. A 
thin fibrous capsule surrounded the granulomas, with discrete 
admixtures of lymphocytes, and macrophages. In some fish granulomas
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Table 2.2. Summary of Micros
Exposed
Day of experiment 
Fish with no lesions 
Fish with lesions 
Total Number of Fish 








:opic Findings in the Liver of Fish 
to 6.7 pM MNNG
0 1 2 3 6 9 12 15 Total
9 11 8 11 10 10 7 9 75
3 1 4 1 2 2 5 3  21
12 12 12 12 12 12 12 12 96
lesions Recognized:
0 1 4 1 2 2 5 3 1 18
1 1 4 1 1 2 5 3 1 18
3 1 2 1 2 2 5 2 I 18
0 2 3 1 2 1 5 3 I 17
1 1 3 1 2 2 1 3 | 14
0 0 0 0 0 0 0 0 1 00 0 0 0 0 0 0 0 | 0
were multiple and/or coalescing. Acid-fast staining was negative for 
acid-fast bacilli or other organisms.
The most important parameter evaluated in these tissues was the 
immunohistochemical identification of apoptotic nuclei, especially in 
the liver, and the three fixatives varied widely in their suitability 
for this procedure (see histogram 2.2). The number of positive cell 
nuclei per 1 mm2 of liver tissue varied from 0 to 2637 in the tissues 
fixed in methacarn. Those for tissues fixed in S.T.F. varied from 0 
to 281, and for the tissues fixed in 10 % formalin counts varied from 
447 to 945.
In the methacarn-fixed tissues, all cells from the various 
tissues present were labeled positive, regardless of the day of the 
experiment. The pepsin tissue digestion step was harsher on 
methacarn-fixed tissues when compared to those fixed in S.T.F. or 10 %
formalin. Moreover, on the methacarn-fixed specimen collected at day
0 of the experiment, no apoptosis counts could be obtained from the 
liver tissue since no liver tissue was left on the slide after the
pepsin digestion step. The cellular detail from tissues fixed in
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S.T.F. was greatly obscured with the chromogen, diaminobenzidine; the 
cell margins, cytoplasm, and nuclei stained strongly with DAB. In 
some well-fixed areas, there was some differential staining between 
positively and negatively labeled apoptotic cells when compared to 
control fish. Cells from tissues fixed in buffered 10 % formalin had 
good differential staining between positive and negatively stained 
apoptotic cells when compared to control fish (see figure 2.3). Less 
tissue artifact and a better ability to withstand the harsh, pepsin 
digestion step was also noted.
Histogram 2.2. Effect of Fixative on 
Immunohistochemical Detection of Apoptosis in 
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Days of Experimant:
Immunohistochemical Detection of Apoptosis in the Liver of Fish 
Exposed to 6.7 pM MNNG or 6.9 mM 2-AF
Mean hepatic immunohistochemical detection of apoptosis in 
Fundulus grandis was performed in 210 fish specimens of a total of 52b 
fish sampled from the three groups (see table 2.3). In the 2-AF
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exposed fish group, the mean hepatic immunohistochemical detection of 
apoptosis ranged from 986 nuclei per 1 mm2 of tissue on day 21 to 2599 
nuclei per 1 mm2 of tissue on day 45 of the experiment. In the MNNG 
exposed fish group, the mean hepatic immunohistochemical detection of 
apoptosis varied from 665 nuclei per 1 mm2 of tissue on day 180 to 2257 
nuclei per 1 mm2 of tissue on day 45 of the experiment. The control 
fish had a mean hepatic immunohistochemical detection of apoptosis 
that varied from 1359 nuclei per 1 mm2 of tissue on day 3 to 2296 
nuclei per 1 mm2 of tissue on day 4 5 of the experiment. The 
distribution of the apoptotic frequencies are illustrated in the 
histogram 2.3.
Figure 2.3. Representative apoptotic labeling features in 
formalin fixed liver tissue from a fish exposed to 6.7 pM MNNG. 
Apoptotic hepatocyte nuclei are labeled by a brown 
diaminobenzidine chromogen deposit. (Hematoxylin, 500X)
Two-factor factorial analysis of variance showed no significant 
group by day interaction (P=0.165; see appendix 2.C.1); thus, 
individual main effects of group and day were evaluated. By looking 
at the least-square means table (see appendixes 2.C.2 and 2.C.3), at 
day 180, significant differences (P=0.005) were found in the apoptotic 
cell counts between the control fish and those treated with MNNG, but
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not between fish treated with MNNG and 2-AF, or between 2-AF treated 
fish and controls.
Histologic evaluation of 525 fish livers revealed a total of 153 
livers with lesions, of which 37 were noted in the control group, 55 
in the MNNG-exposed group, and 61 in the 2-AF-exposed group. The 
frequency and type of liver lesions found in each group sample per day 
of experiment are summarized in table 2.4.
In the control group, most of the lesions found were 
inflammatory, and most were recognized by day 3 of the experiment.
Most of the inflammatory lesions were mild and consisted of 
perivascular and pericholangial admixtures of lymphocytes, 
eosinophilic granular cells, and histiocytes. Some fish had 
granulomas, which occurred as distinct collections of epithelioid 
macrophages surrounding golden-brown material and necrotic debris; a 
thin fibrous capsule is noted at the periphery of the granulomas with 
focal collections of lymphocytes.
Hepatocytes in adjacent areas had cytoplasmic vacuolar changes, 
which consisted of increased number of variably sized, clear vacuoles. 
Apoptosis was noted mainly in areas associated with mononuclear 
inflammatory cell infiltrates. A total of 6 fish livers had a 
distinct, discrete non-expansile nodular collection of densely 
eosinophilic hepatocytes (eosinophilic focus), which maintained the 
normal tubulo-sinusoidal architectural arrangement of adjacent 
hepatocytes (see figure 2.4). No neoplastic changes were found in any 
of the control fish livers.
In the MNNG-exposed group, there were about equal numbers of 
hyperplastic, inflammatory, and vacuolar changes noted in the liver 
specimens examined. Inflammatory changes were similar to but milder 
than those described for the control fish group, and their frequency 
was spread throughout the experiment. Hyperplastic changes were more 
frequently noted on days 45, 90, and 180 of the experiment. These
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were characterized by discrete hepatocytic hyperceiluiar clusters or 
nodules that varied to widespread or diffuse hepatocytic 
hypercellularity, with increased cytoplasmic basophilia and vacuolar 
change. The discrete, nodular collections of hepatocytes with 
basophilic cytoplasm were recognized as basophilic foci (see figure
2.5). Hepatocytic megalocytosis and megalokaryosis were frequently 
recognized in hyperplastic lesions from several specimens (see figure
2.6). The normal tubulo-sinusoidal architectural arrangement was 
maintained in all hyperplastic changes, however. Apoptosis was noted 
throughout these hyperplastic changes. Two liver neoplasms were 
recognized, at days 9 and 180, respectively. The microscopic features 
of the neoplasm found at day 9 were consistent with a
cholangiocellular carcinoma (see figure 2.7), which was characterized 
by expansile proliferation of pleomorphic polygonal cells arranged in 
tubular structures within a fibrous stroma. The hyperchromatic nuclei 
was round to oval with moderate anisokaryosis. Mitotic figures are 
rare and apoptosis vary from 1-2 per hpf. The cytoplasm was 
eosinophilic and vacuolated. The histologic features of the neoplasm 
noted at day 180 were commensurate with a hepatocellular carcinoma 
(see figure 2.8); the predominant features consisted of a discrete 
focus of neoplastic pleomorphic hepatocytic cells with loss of normal 
architectural tubulo-sinusoidal arrangement. The nuclei were 
eccentrically located, round to oval, and hypochromatic with marked 
anisokaryosis, and prominent amphophilic nucleoli. Mitotic figures 
were not seen. The cytoplasm was basophilic with a few eosinophilic 
vacuoles.
In the 2-AF-exposed group, inflammatory changes were also spread 
throughout the experiment, and the features were similar to those 
described above. Hepatocytic hyperplasia was also noted in the liver
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Table 2.4. Mean Hepatic Immunohistochemically Detected 
Apoptotic Nuclei per mm2 of Liver Tissue From Fish Exposed
6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Expoaed Group
Day Mean Std. Dev. % RSD*
0 1045 215 20.57
3 1808 1107 61.23
9 1106 667 60.31
21 986 543 55.07
45 2599 1184 45.56
90 1506 467 31.01
180 1285 840 65.37
Control Group
Day Mean Std. Dev. % RSD
0 1881 1048 55.72
3 1359 573 42.16
9 1547 650 42.02
21 1361 724 53.20
45 2296 689 30.01
90 1499 837 55.84
180 1621 950 58.61
6.7 pM MNNG-Exposed Group
Day Mean Std. Dev. % RSD
0 1070 288 26.92
3 1485 898 60.47
9 1502 972 64 .71
21 892 357 40.02
45 2257 457 20.25
90 1180 681 57 .71
180 665 696 104.66
* % RSD = (Std. Dev./Mean) 100 %
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Histogram 2.3. Mean Immunohistohamical Detection 
of Apoptosis in the Liver of JTundulus grandis 












and it occurred more frequently at day 4 5 and resembled those 
described for the fish exposed to MNNG (see figure 2.9). Again, the 
association of apoptosis with areas of inflammation and hyperplasia 
was recognized. Neoplastic changes were noted in two livers, one at 
day 4 5 and one at day 180. The microscopic features of these tumors 
resembled those described for cholangiocellular carcinoma in the fish 
liver from the MNNG-exposed group, with the exception that the tumor 
noted at day 180 of the experiment was more anaplastic and aggressive 
with multiple neoplastic microsatellites within the liver (see figure 
2.10) .
The total body weight of the entire fish group sampled each time 
doubled by the end of the experiment. The range of the total sample 
weight, which consisted of 25 fish per sample, varied from 75 grams at 
day 0 to 150 grams at day 180 of the experiment (see histogram 2.4).
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Discussion 
Degradation of MNNG
This experiment suggests that the total amount of n-methyl-n'-nitro-n- 
nitrosoguanidine (MNNG) exposure to fish need not be longer than 70 
minutes since the compound would be totally degraded by that time. 
Observation of the area under the curve and of the retention time for 
the saltwater MNNG solution suggest that this compound dissolves less 
readily in saltwater than in distilled water. It is known that this 
compound is highly sensitive to light and that this may have also have 
had an effect in its rapid degradation. Other variables which could 
have had an effect on the compound was the pH of the saltwater, which 
for this experiment was 8.56. The pH of the distilled water was 7.01.
Effect of Fixative on ZHC Detection of Apoptosis in Livers of
Fish Exposed 34 pM MNNG
Tissue morphology and immunohistochemical detection of apoptosis 
were best preserved in the 10 % formalin fixed tissue group. Aldehyde 
fixatives, such as formalin and gluteraldehyde, preserve structure and 
immobilize antigens to a much greater degree than do coagulant 
fixatives, such as alcohols (methacarn), and are the most commonly 
used fixatives for immunohistochemistry (Larsson 1993). Coagulant 
fixatives are often used to preserve immunoreactivities of large 
proteins such as immunoglobulins, filament proteins, and receptors 
(Larsson 1993). The mode of tissue fixation of Strek's tissue 
fixative is unknown.
Perhaps the most interesting finding was the widespread, intense 
immunohistochemical detection of apoptosis of tissue fixed in 
methacarn. An explanation for this finding can not be given precisely 
at this time. Several questions come to mind: Is the reaction of
this coagulative fixative with the cellular DNA similar to that of the 
DNase-I used to induce DNA strand breaks in the positive controls? If 
so, what component of the mixture, which consists of 60 % methanol,
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Table 2.4. Summary of the Types and Frequency of Hepatic Lesions 
Recognized in Fundulus grandis fish per sample per group
Control Day of
Experiment
0 3 9 21 45 90 180 Total
Fish Livers With Lesions 6 12 7 4 1 1 6 37
Fish Livers With No Lesions 19 13 18 21 24 24 19 138
Total Number of Fish: 25 25 25 25 25 25 25 175
Type of Hepatic Lesions
Hyperplastic 0 0 0 0 0 0 3 3
Vacuolar/Degenerative 1 12 1 1 0 0 1 16
Inflammatory, Mixed 6 12 5 2 1 1 4 31
Apoptotic Necrosis 2 10 0 0 1 0 1 14
Coagulative Necrosis 0 0 0 0 0 0 0 0
Neoplasia 0 0 0 0 0 0 0 0
Eosinophilic Foci 0 0 1 2 0 0 3 6
Basophilic Foci 0 0 0 0 0 0 0 0
MNNG Day of
Experiment
0 3 9 21 45 90 180 Total
Fish Livers With Lesions 6 4 12 2 9 9 13 55
Fish Livers With No Lesions 19 21 13 23 16 16 12 120
Total Numbar of Fish: 25 25 25 25 25 25 25 175
Type of Hepatic Lesions
Hyperplastic 0 0 1 0 7 7 11 26
Vacuolar/Degenerative 3 2 8 1 7 6 6 33
Inflammatory, Mixed 6 4 10 1 2 2 2 27
Apoptotic Necrosis 3 0 9 0 0 6 6 24
Coagulative Necrosis 0 0 0 0 0 1 1 2
Neoplasia 0 0 1 0 0 0 1 2
Eosinophilic Foci 0 0 0 1 0 0 0 1
Basophilic Foci 0 0 0 0 0 5 3 8
2-AF Day of
Experiment
0 3 9 21 45 90 180 Total
Fish Livers With Lesions 5 9 6 10 13 10 8 61
Fish Livers With No Lesions 20 16 19 15 12 15 17 114
Total Number of Fish: 25 25 25 25 25 25 25 175
Type of Hepatic Lesions
Hyperplastic 0 0 0 1 10 8 6 25
Vacuolar/Degenerative 1 3 3 2 11 8 3 31
Inflammatory, Mixed 5 8 4 7 2 2 1 29
Apoptotic Necrosis 1 2 0 7 4 6 1 21
Coagulative Necrosis 0 0 0 0 0 0 0 0
Neoplasia 0 0 0 0 1 0 1 2
Eosinophilic Foci 0 0 0 0 0 1 0 1
Basophilic Foci 0 0 0 1 1 7 0 9
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Figure 2.4. Section of an eosinophilic focus found in the liver 
of a control fish (Hematoxylin and eosin, 78.75X)
Figure 2.5. Section of a basophilic focus found in the liver of 
fish exposed to 6.7 |oM MNNG (Hematoxylin and eosin, 200X)
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Figure 2.6. Representative example of hepatic megalocytosis and 
megalokaryosis found in the liver of fish exposed to 6.7 |iM MNNG 
(Hematoxylin and eosin, 500X)
Figure 2.7. Section of a probable cholangiocellular carcinoma 
found at day 9 of the experiment in the liver of a fish exposed 
to 6.7 pM MNNG (Hematoxylin and eosin, 78.75X)
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Figure 2.8. Section of a hepatocellular carcinoma found at day 
180 in the liver of a fish exposed to 6.7 MNNG (Hematoxylin 
and eosin, 200X)
Figure 2.9. Representative example of a section of liver with 
diffuse hepatocellular hyperplasia found at day 45 in the liver 
of fish exposed to 6.9 mM 2-AF (Hematoxylin and eosin, 200X)
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Figure 2.10. Section of a probable cholangiocellular carcinoma 
found at day 180 in the liver of a fish exposed to 6.9 mM 2-AF 
(Hematoxylin and eosin, 200X).
Histogram 2.4. Variation of Total Sample Body 
Weight of Fundulus gx-andls
1 6 0  ; : :   : —  : :------
0 3 9 21 45 90 180
Days of Experiment
30 c chloroform, and 10 % glacial acetic acid, if not the mixture 
itself, causes such changes? Can we use the less expensive methacarn- 
fixed tissue as a positive control rather than use of the more 
expensive DNase-I, which requires special storage conditions? The use 
of methacarn-fixed tissue could be an inexpensive, more practical way 
to obtain positive control tissue for the application of the IHC 
detection of apoptosis in fish specimens. Thus, for fish tissues, 10'.-
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formalin is a better fixative for preservation of tissue morphology 
and for immunohistochemical detection of apoptosis than methacarn or 
Strek's tissue fixatives.
IHC Detection of Apoptosis in Livers From Fish exposed to
6.7 pM MNNG or 6.9 mM 2-AF
The significant reduction in the immunohistochemical detection 
of apoptosis between fish treated with MNNG and controls suggest that 
the process of apoptosis is suppressed as a result of exposure to 
MNNG. It has been demonstrated that dysfunction of the process of 
apoptosis is important in the pathogenesis of neoplasia (Bursch, 
Oberhammer et al. 1992; Carson and Ribeiro 1993; Thompsom 1995;
Bosnian, Visser et al. 1996; Duke, Ojcius et al. 1996). This 
alkylating agent, which is a known carcinogen that causes DNA damage, 
has been related to neoplastic processes in fish, including fish such 
as medaka (Oryzias latipes), Fundulus spp., and others (Moore and 
Myers 1994; Bunton and Wolfe 1996). The mechanism by which apoptosis 
is suppressed as a result of MNNG exposure is unknown. Possible 
involvement of the product of the p53 gene will be evaluated in a 
later chapter.
The absence of a significant difference found between fish 
treated with MNNG and 2-AF suggests that the process of apoptosis is 
affected also in fish treated with 2-AF. However, no significant 
differences were established between fish treated with 2-AF and those 
from the control group in spite of finding two liver neoplasms.
It has been suggested that native fish, like Fundulus grandis, 
may be less susceptible to carcinogens than laboratory-reared species, 
such as medaka (Moore and Myers 1994) . However, the decline through 
time in the mean immunohistochemical detection of liver apoptosis as 
well as the increased number of putative preneoplastic lesions, like 
hepatocellular basophilic foci, megalocytosis, and karyomegaly in both 
MNNG and 2-AF treatment groups, makes Fundulus grandis a potentially
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good model for the study of chemically-induced carcinogenesis. It is 
postulated that in longer or repeated exposure conditions, tumors 
would be induced by these two compounds.
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CHAPTER 3. IMMUNOHISTOCHEMICAL DETECTION OF PROLIFERATING CELL 
NUCLEAR ANTIGEN IN THE LIVER OF FUNDULUS GRANDIS AFTER EXPOSURE TO 
N-METHTL-N' -NITRO-N-NITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
In multicellular organisms homeostasis is maintained through a 
balance between cell death and cell proliferation. Dysfunction of 
this balance is believed to be important in the pathogenesis of 
cancer. The assessment of cell proliferation has become a common 
monitor of homeostatic host response to cell injury. This may be 
achieved in several ways. Some of which include (1)counting mitotic 
figures in tissue sections, (2)measuring radioactive tritiated 
thymidine uptake, or (3)measuring uptake of the non-radioactive 
thymidine analog, bromodeoxyuridine (BrdU). Another method for 
determining mitotic activity is by immunohistochemical localization of 
endogenous proteins, like proliferating cell nuclear antigen (PCNA), 
the expression of which is closely related to cell replication (Hall, 
Levison et al. 1990; Ortego, Hawkins et al. 1994). In the past few 
years fish have become popular models in the study of carcinogenesis. 
But only in a few published articles has the mammalian PCNA 
methodology been successfully used in fish (Hinton 1994; Ortego, 
Hawkins et al. 1994).
An application of PCNA for the assessment of cell proliferation 
and possible promotional effects of the alkylating agent, n-methyl-n'- 
nitro-n-nitrosoguanidine (MNNG), and of the polycyclic aromatic 
hydrocarbon, 2-aminofluorene (2-AF) in liver and liver lesions of fish 
exposed to these compounds was studied by immunohistochemical (IHC) 
methods. To improve methodology of the IHC technique used, several 
preliminary studies were needed. These included a study to determine 
the stability of MNNG in saltwater, a study to evaluate suitability of 
different tissue fixatives on IHC localization of PCNA in fish
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tissues, and, lastly, a study to compare and evaluate cell 
proliferation in fish liver subjected to exposure of MNNG and 2-AF. 
Materials and Methods
Experimental Design
The study on the stability of MNNG in saltwater, to which fish 
would be exposed over a time course in later experiments, was already 
described in chapter 2.
To determine the most suitable tissue fixative for use in later 
experiments, livers from fish exposed to MNNG were fixed in 1 of 3 
different fixatives: 10 % formalin, methacarn, or Strek's tissue 
fixative. Livers were processed by routine techniques and subjected 
to immunohistochemical labeling techniques to identify the endogenous 
protein, proliferating cell nuclear antigen, using the clone PCNA- 
PC10. The overall tissue morphology and clarity and specificity of 
staining characteristics were subjectively compared.
Finally, groups of fish were exposed to MNNG or 2-AF at two 
different time durations and at two different concentrations, cellular 
proliferative activity was quantitatively determined by cytometry and 
tissue changes were evaluated histologically.
The following sections were already described in chapter 2: 
fish and fish housing, rationale for using the liver as the target 
organ, compounds used, dosing rationale and route of administration, 
determination for the stability of MNNG in saltwater, preparation of 
feed containing 2-AF, cytometry, and the statistical analysis.
The same procedures described in chapter 2 for evaluation of the 
effect of three types of fixative on immunohistochemical detection of 
apoptosis in livers from fish exposed to 6.7 pM of MNNG and for the 
evaluation of immunohistochemical detection of apoptosis in liver of 
fish exposed to 6.7 pM MNNG and 6.9 mM 2-AF were used, except that
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additional, serial tissue sections were made for immunohistochemical 
detection of PCNA.
Immunohistochemical Technique for Identifying PCNA
in Fish Tissues
After processing and embedding the tissues in paraffin, 2-3 nm 
sections were cut and mounted on charged slides, then deparaffinized 
and rehydrated to distilled water. The tissue sections were stained 
using the avidin-biotin complex method described by Hsu (Hsu, Raine et 
al. 1981). Antigen unmasking was performed in a pressure cooker (Shi, 
Cote et al. 1977; Norton, Jordan et al. 1994) with 0.01 M Citrate 
buffer, pH 6.0. An avidin/biotin blocking step was used to block non­
specific staining. The primary antibody used was mouse anti- 
proliferating cell nuclear antigen,PC-10 (Vector, California). 
Biotinylated, horse anti-mouse (Vector) was used as the secondary 
antibody. For negative control normal mouse IgG was substituted for 
the primary antibody. For positive control a section of formalin- 
fixed, paraffin-embedded human colon was used. The entire staining 
procedure was carried out at room temperature unless otherwise noted.
Briefly, endogenous peroxidase activity was blocked by immersing 
slides in 0.3 % hydrogen peroxide in methanol for 30 minutes. Slides 
were rinsed in buffer, 10 mM Phosphate Buffer Saline + BRIJ (PBS-BRIJ, 
Sigma), then incubated for 45 minutes with diluted normal horse serum; 
the excess serum was removed, and diluted mouse anti-proliferating 
cell nuclear antigen was placed on slides and incubated for 60 
minutes. The primary antibody was diluted according to information on 
Primary Antibody Staining Evaluation Quality Control Sheet (1:100 
dilution, DAKO). Slides were rinsed in buffer (PBS-BRIJ) and the 
Avidin (Avidin/Biotin Flush Kit) was applied for 15 minutes. Slides 
were rinsed in PBS-BRIJ buffer, and the Biotin (Avidin Biotin Flush 
Kit) was applied for 15 minutes. Slides were rinsed in PBS-BRIJ 
buffer and the Avidin-Biotin Complex was applied and incubated on
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slides for 45 minutes at room temperature. Slides were rinsed in PBS- 
BRIJ buffer, and the chromogen, diaminobenzidine (DAB), was applied 
for 5 to 10 minutes. Slides were rinsed in distilled water to stop 
chromogen reaction. The slides were counterstained either with 
Nuclear-Fast Red or Mayer's Hematoxylin, then dehydrated, cleared, and 
mounted in a resinous media.
Results 
Effect of Fixative on Immunohistochemical Detection of PCNA, 
PC-10 in Livers of Fish Exposed to 6.7 pM MNNG
Detection of the proliferating nuclear cell antigen (PCNA), PC10 
clone, was noted in normally proliferating tissues such as primary 
filament epithelium of the gills, hematopoietic tissues, thymus, 
retina, alimentary tract, liver, testis, and ovaries regardless of the 
fixative used. Results obtained from the effect of type of fixative 
on immunohistochemical detection of PCNA in liver cells from fish 
exposed to 6.7 pM MNNG are shown in table 3.1. The range of positive 
PCNA-labeled cell nuclei varied from 0 to 754 in the methacarn-fixed 
tissues; from 0 to 358 in Strek's fixed tissues; and from 0 to 690 in 
10 % formalin fixed tissues. In liver tissues, where no PCNA-labeling 
occurred or noted, most of the tissues fell off the slides during or 
after the heat-activated antigen retrieval step. Variation in the 
intensity of nuclear staining was noted in all fixative groups. 
Cytoplasmic staining was noted in both methacarn and Strek's fixed 
tissues. The greatest variation in number of PCNA-labeled cell nuclei 
was seen in tissues in Strek's fixative. The number of PCNA positive 
cell nuclei from tissues fixed in 10 % formalin showed less variation 
and showed a steady increase in positive PCNA-labeled nuclei, which 
peaked by day 9 of the experiment. The variation and distribution of 
immunohistochemical detection of PCNA in liver tissues as a function 
of type fixative used are best illustrated on histogram 3.2. Figure
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3.1 shows representative PCNA staining characteristics obtained from 
fish liver tissue fixed in 10 % formalin fixative.
Table 3.3. Effect of Fixative on Immunohistochemical 
Detection of PCNA in Livers from Fish Exposed to 6.7 ftM MNNG
Fixative
Day of Methacarn Strek's Formalin
Experiment (No. positive cell nuclei/mm2 of tissue) (No. positive cell nuclei/mm2 of tissue) (No. positive cell nuclei/mm2 of tissue)
0 166 249 140
1 754 6 140
2 741 0 153
3 13 6 166
6 0 38 332
9 179 358 690
12 613 64 383
15 0 38 0
Histogram 3.2. Immunohistochemical detection of PCNA- 
PC10 in the liver of Fundulus grandis Fish Exposed to
6.7 pM MNNG in 5ppt Saltwater
0 1 2 3 6 9 12 15
Days of Experiment
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Figure 3.1. Section of a 10 % formalin fixed liver tissue from 
a fish exposed to 6.7 pM MNNG illustrating representative PCNA- 
PC10 staining characteristics (Nuclear Fast Red, 200X)
Results of the quality of fixation obtained with the three
fixatives used, methacarn, Strek's, and 10 % formalin, as well as the
histological changes observed in these fish were described in the
corresponding section from chapter 2.
Immunohistochemical. Detection of PCNA in the Liver of Fish 
Exposed to 6.7 JIM MNNG or 6.9 mM 2-AF
Hepatic immunohistochemical detection of PCNA-PC10 was performed 
in a total of 210 fish specimens randomly selected from a total of 525 
fish sampled from all of the different groups. Mean numbers of PCNA- 
labeled nuclei per mm2 of liver tissue per sampling day are shown in 
table 3.3. The means varied from 936 to 2849 in the 2-AF exposed fish 
group; from 870 to 3220 in the MNNG exposed fish group; and from 895 
to 2413 in the control fish group. The histogram 3.3 illustrates the 
comparative distribution of immunohistochemical detection of PCNA 
between control fish and those exposed to 2-AF and MNNG.
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Analysis of the data obtained from immunolocalization of 
proliferating cell nuclear antigen in the liver of Fundulus grandis 
fish exposed to MNNG and 2-AF is summarized in appendixes 3.A to 3.C. 
Two-factor factorial analysis of variance revealed significant 
differences in group by sampling day interaction (P = 0.003), with 
highly significant differences (P = 0.0001) obtained at day 9 of the 
experiment between the PCNA least-square means of the treated fish 
groups and that of the control fish group. However, no significant 
differences (P = 0.339) were found between the PCNA least-square means 
of the MNNG and the 2-AF treated fish groups at day 9 of the 
experiment. In other words, the differences between the mean level of 
immunohistochemically detected PCNA in the livers of treated versus 
control fish were highly significant only at day 9 of the experiment 
(group by day interaction) regardless of the compound used. However, 
no significant differences were found between the mean levels of 
immunohistochemically detected PCNA in the livers of fish treated with 
MNNG or 2-AF at day 9 of the experiment or at any other day.
Histologic evaluation of the 525 fish livers examined was 
already described in chapter 2.
Discussion 
Effect of Fixative on IHC Detection of PCNA in Livers of Fish 
Exposed 6.7 |iM MNNG
Preservation of tissue morphology and application of the 
mammalian methodology for the immunohistochemical localization of PCNA 
was best preserved by 10 % formalin solution. As discussed in chapter 
2, aldehyde fixatives, such as formalin and gluteraldehyde, preserve 
structure and immobilize antigens to a much greater degree than do 
coagulant fixatives, such as alcohols (methacarn), and are the most 
commonly used fixatives for immunohistochemistry (Larsson 1993).
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Table 3.3. Mean Hepatic Immunohistochemically Detected PCNA Positive 
Nuclei per mm2 of Liver Tissue From Fish Exposed 
to 6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Expoa ad Group
Day Mean Std. Dev. % RSD*
0 1506 880 58.43
3 2784 1421 51.04
9 2849 668 23.45
21 2414 632 26.18
45 1791 807 45.06
90 1078 626 58.07
180 936 392 41.88
Day
Control Group
Mean Std. Dev. % RSD
0 1637 1546 94.44
3 2413 1190 49.32
9 1656 635 38.35
21 2111 598 28.33
45 1213 394 32.48
90 895 505 56.42
180 1058 644 60.87
6.7 pM MNNG-Expoaod Group
Day Mean Std. Dev. % RSD
0 870 309 35.52
3 1881 690 36.68
9 3220 1433 44 . 50
21 1839 742 40. 35
45 1693 536 31.66
90 1533 1368 89.24
180 1328 440 33.13
* % RSD = (Std. Dev./Mean) 100 %
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Histogram 3.3. Maan Iasaunohistochezaical dataction 
of PCNA (PC-10) in the Liver of Fimdulus grandxa 
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Ioununohistochemical Detection of PCNA in Livers From Fish 
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
The data obtained from the immunohistochemical detection of PCNA 
suggests that after chemically-mediated cell injury, fish liver cells 
respond by a significant increase in the level of PCNA expression that 
peaks by day 9 of the experiment regardless of the chemical compound 
used. Histologically, however, peak number of hyperplastic changes 
occurred by day 4 5 of the experiment in both MNNG and 2-AF treated 
groups (see corresponding section on chapter 2). Therefore, the 
expression and detection of PCNA as an index of proliferation occurs 
much earlier than histologic evidence of proliferation (hyperplasia) 
is noted. It is interesting to note that it is also at day 45 of the 
experiment when the greatest detection of apoptosis was noted in this 
experiment (see chapter 2). These observations, taken together, may 
represent a balanced homeostatic response of the liver of Fundulus
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grandis as a result of exposure to MNNG or 2-AF. Concurrent use of a 
marker for cell death, or apoptosis, with one of proliferation greatly 
enhances the assessment of the effect of these compounds on liver cell 
proliferation and on the study of hepatic carcinogenesis.
These experiments indicate that PCNA, PC-10, can be effectively 
used as an index of cell proliferation in liver and liver lesions 
found in Fundulus grandis fish. And application of the mammalian 
methodology for immunolocalization of PCNA in fish tissues are 
consistent with previously published reports (Hinton 1994; Ortego, 
Hawkins et al. 1994). Also, that Fundulus grandis may be a useful 
model for the study of liver cell proliferation and chemical 
carcinogenesis.
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CHAPTER 4. DETECTION OF p53 IN THE LIVER OF FUNDULUS GRANDIS AFTER 
EXPOSURE OF N-METHYL-N' -NITRO-N-NITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
Damage to the cellular DNA can result in either restoration of 
its genomic integrity, or in activation of the cell's own suicide 
mechanism, apoptosis, resulting in the elimination of the affected 
cell from the rest of the population. The normal (wild type) p53 gene 
protein suppresses the division of genetically damaged or altered 
cells by causing a pause in the cell cycle and by promoting exit from 
it through apoptosis (Sidransky and Hollstein 1996). This function of 
p53 as "guardian of the genome" may extend to a role in initial 
monitoring and repair of DNA damage in addition to direct control of 
cell growth and death (Lane 1992). The structural evolution of the 
p53 gene protein was reviewed and summarized by Soussi(Soussi, Caron 
de Fromentel et al. 1990). Comparison of the predicted amino acid 
sequences of the p53 gene protein from human, monkey, rat, chicken, 
Xenopus spp., and rainbow trout revealed five highly conserved 
domains. Rainbow trout p53 showed 90 % homology to the human p53 
sequence within these five domains (Van Beneden and Ostrander 1994). 
Detection of p53 protein in some fish cell lines has also been 
demonstrated (Smith, Yeleswarapu et al. 1991). Immunohistochemical 
detection of p53 protein (PAb 421 p53 protein clone) has been reported 
in the fish Rivulus ocellatus marmoratus (Goodwin and Grizzle 1994a; 
Goodwin and Grizzle 1994b). Just recently, the p53 gene was cloned in 
the Japanese medaka (Oryzias latipes) and the mutational hotspots in 
MNNG-exposed fish were evaluated (Krause, Rhodes et al. 1997) .
In this study, immunohistochemical studies were performed to 
evaluate and compare the detection and expression of p53 in liver and 
liver lesions from fish exposed to the alkylating agent, n-methyl-n'- 
nitro-n-nitrosoguanidine (MNNG) and to the polycyclic aromatic
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hydrocarbon, 2-aminofluorene (2-AF). Preliminary studies required, 
however, to improve the methodology employed consisted of: a)studies 
on the stability of MNNG in saltwater since the fish species used 
lives in saltwater, b) studies on the suitability of various tissue 
fixatives on immunohistochemical detection of p53, c) studies on the 
suitability of various commercially available anti-p53 antibody 
clones, and lastly, d) a study on the sequential expression and 
immunohistochemical detection of p53 protein in livers and liver 
lesions of fish exposed to MNNG and to 2-AF.
Materials and Methods 
Experimental Design
The study on the stability of MNNG in saltwater, to which fish 
would be exposed over a time course in later experiments, was already 
described in chapter 2.
To determine the most suitable tissue fixative and anti-p53 
antibody clone for use in later experiments, livers from fish exposed 
to MNNG were fixed in 1 of 3 different fixatives: 10 % formalin, 
methacarn, or Strek's tissue fixative. Livers were processed by 
routine techniques and subjected to immunohistochemical (IHC) labeling 
techniques to identify the endogenous p53 protein using the following 
anti-p53 antibody clones: DO-1, DO-7, PAb 240, PAb 421, and CM-1. The 
overall tissue morphology and clarity and specificity of staining 
characteristics were subjectively compared. Finally, groups of fish 
were exposed to MNNG or 2-AF at two different time durations and at 
two different concentrations, and the immunohistochemical detection of 
p53 was quantitatively determined by cytometry.
The following sections were described previously in chapter 2: 
fish and fish housing, rationale for using the liver as the target 
organ, compounds used, dosing rationale and route of administration, 
determination for the stability of MNNG in saltwater, preparation of 
feed containing 2-AF, cytometry, and the statistical analysis.
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The same procedures described in chapter 2 for evaluation of the 
effect of three types of fixative on immunohistochemical detection of 
apoptosis in livers from fish exposed to 6.7 pM of MNNG and for the 
evaluation of immunohistochemical detection of apoptosis in liver of 
fish exposed to 6.7 (iM MNNG and 6.9 mM 2-AF were used, except that 
additional, serial tissue sections were made for immunohistochemical 
detection of p53.
Method for IHC Detection of p53 Protein in Fish Tissues
Following tissue processing and paraffin embedding, serial 
sections 2-3 urn thick were cut and mounted on charged slides, then 
deparaffinized and rehydrated to distilled water. The tissue sections 
were stained using the avidin-biotin complex method described by Hsu 
(Hsu, Raine et al. 1981). Antigen unmasking was performed in a 
pressure cooker (Shi, Cote et al. 1977; Norton, Jordan et al. 1994) 
with 0.01M Citrate buffer, pH 6.0. The entire staining procedure was 
carried out at room temperature unless otherwise noted. Briefly, 
endogenous peroxidase activity was blocked by immersing slides in 0.3% 
hydrogen peroxide in methanol for 30 minutes. For the anti-p53 
monoclonal antibody proteins, PAb 240, PAb 421, DO-1, and DO-7, the 
slides were covered with 2 % normal horse serum (1:50), and for the 
anti-p53 polyclonal antibody protein, CM-1, the slides were covered 
with 2 % normal goat serum (1:50); all were incubated for 45 minutes. 
An avidin/ biotin blocking step was used to block non-specific 
staining. The primary antibody for the p53 monoclonal proteins, mouse 
anti-p53 (various clones), was applied on the slides and incubated 
overnight at 4 °C at a dilution rate of 1:150 for p53 clone PAb 240, 
1:10 for p53 clone PAb 421, 1:100 for p53 clone DO-1, and 1:50 for p53 
clone DO-7. The primary antibody used for the p53 polyclonal protein, 
CM-1, was rabbit anti-p53 CM-1 diluted 1:100. Normal mouse IgG 
(Vector, California) and normal rabbit IgG (Vector) diluted at the
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same concentration as their respective primary antibodies were 
substituted for primary antibody for the negative controls. A canine 
control was established as dual positive and negative control with SV- 
40 transformed and untransformed altered canine tracheal cells (ACT-8 
and ACT-8/SV40 cells, provided by Dr. Tierney, Inhalation Toxicology 
Research Institute, New Mexico) and normal canine liver tissue 
section. Biotinylated horse anti-mouse (1:200) and biotinylated goat 
anti-rabbit were incubated for 30 minutes (1:200). The avidin-biotin 
complex was prepared according to manufacturer's directions and 
applied for 45 minutes. Slides were rinsed in PBS between each step, 
except between the normal goat or normal horse sera and primary 
antibody steps. The chromogen, diaminobenzidine, was utilized. The 
slides were counterstained either with Mayer's hematoxylin or Nuclear- 
Fast Red, then dehydrated, cleared, and mounted in a resinous media. 
Rasults
Effect of Three Types of Fixatives on Immunohistochemical
Detection of p53 Protein in Liver Tissue Using Five anti-p53
Antibody Clones
No detection of distinct nuclear DAB staining was found in any 
of the liver specimens tested with the anti-p53 monoclonal (PAb 240, 
PAb 421, DO-1, and DO-7) or polyclonal antibodies (CM-1), regardless 
of the fixative used. However, throughout the entire length of the 
experiment, distinct nuclear staining was noted with the monoclonal 
anti-p53 antibody PAb 240 in the epithelium of gills, oral mucosa, and 
epidermis of the whole-fish specimens fixed in 10 % formalin (see 
figures 4.1, 4.2, and 4.3). Using a squared (grid) graticule, the 
total number of DAB-stained gill epithelial cell nuclei was counted 
from a total of 5, randomly chosen fields counted at 40-X; the average 
was divided by a conversion factor of 0.1770 mm, and reported as 
number of cells per linear mm of tissue ( see table 4.1).
The number of p53 positive cell nuclei/linear mm of gill tissue 
varied from 86 to 485 in the formalin fixed specimens, and from 0 to
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626 in the methacarn fixed tissues. No immunohistochemical detection 
of p53 was recognized in any of the Strek's fixed tissues.
Distribution of the p53 immunohistochemical detection on gill tissues 
are best illustrated in the histogram 4.2. Results on the quality of 
fixation obtained with the three fixatives used, methacarn, Strek's, 
and 10 % formalin, as well as the histological changes observed in 
these fish were described in the corresponding section from chapter 2 .
Immunohistochemical Detection of p53 protein (PAb 240) in the
Liver of Fish Exposed to 6.7 |iM MNNG and 6.9 mM 2-AF
Mean levels of immunohistochemically detected hepatic p53 
protein per experimental day sampled from fish exposed to MNNG and 2- 
AF are shown on table 4.3, and the statistical analysis of the data 
obtained are shown in appendixes 4.A to 4.C. In the 2-AF exposed fish
Figure 4.1. Representative p53-PAb 240 Staining of the Gills 
(Formalin Fixed Tissue, Hematoxylin, 200X)
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Figure 4.2. Representative p53-PAb 240 Staining of Oral Mucosa 
From Fish (Formalin Fixed Tissue, Hematoxylin, 200X)
Figure 4.3. Representative p53-PAb 240 Staining of The 
Epidermis From Fish Skin (Formalin Fixed Tissue, Hematoxylin, 
200X)
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Table 4.1 Effect of Type of Fixative on IHC Detection of p53 (PAb 
240) in the Gills From Fish Exposed to 6.7 MNNG
Fixative
Day of Methacarn Strek's Formalin
Experiment (No. of positive (No. of positive (No. of positive
cell nuclei/ mm of cell nuclei/ mm cell nuclei/ mm of
0 0 0 86
1 0 0 320
2 188 0 231
3 162 0 244
6 0 0 130
9 626 0 180
12 215 0 485
15 345 0 350
Histogram 4.2. Imminohistochamical detection of 
p53 (PAb 240) in tbe Gills of Fundulus grandis Fish 
Exposed to 6.7 (lM MNNG
| □Methacarn j 














group the mean sample p53 levels varied from 0 to 21; those from the 
MNNG exposed fish group varied from 1 to 75; and those for fish in the 
control group varied from 1 to 4. The highest level of p53 positive 
nuclei was detected on the experiment day 180 in the MNNG exposed fish 
group. The difference in the population means between this MNNG 
exposed fish group and those from the 2-AF exposed and the control
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fish groups is highly significant (P=0.0001) . Two factor factorial 
analysis of the p53 least-square means revealed highly significant 
group by day interaction (P=0.0001). A close look at the group main 
effect, revealed highly significant (P=0.0001) differences between the 
MNNG exposed fish and the control fish groups. However, the least- 
square means of the 2-AF and the MNNG exposed fish groups were not 
significantly different, nor were the least-square means of the 2-AF- 
exposed fish and the control fish groups. Sampling-day main effect 
least-square means showed highly significant differences between 
sampling-day 180 and the rest of the sampling days. Moreover, the 
least-square means of the MNNG exposed fish at sampling day 180 was 
significantly different (P=0.0001) from the least-square means of the 
2-AF-exposed fish and of the control fish groups regardless of the day 
sampled. Immunohistochemical detection of p53 in the liver of fish 
exposed to MNNG and 2-AF is illustrated in the histogram 4.3.
Histologic evaluation of the 525 fish livers examined was 
already described in chapter 2. Figure 4.4 illustrate staining for 
p53 PAb 240 obtained in the liver of a fish exposed to 6.7 jiM MNNG at 
day 180 of the experiment.
Discussion 
Effect of Three Types of Fixatives on Immunohistochemical
Detection of p53 Protein in Liver Tissue Using Five anti-p53
Antibody Clones
Tissue morphology and immunohistochemical detection of p53 were 
best preserved in the 10 % formalin fixed tissue. Use of aldehyde and 
coagulant fixatives for immunohistochemistry was discussed in chapter 
2. Manufactures of some of the anti-p53 proteins used (DO-1 and PAb- 
240) suggested the use of methacarn as the fixative of choice. It was 
suggested that the clone PAb-421 be used on frozen sections, usually 
post-fixed in paraformaldehyde solution. The rest of the p53 protein 
clones were suggested to be used on 10 % formalin as the fixative of
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Table 4.3. Mean He_patic Immunohistochemically Detected p53 
Positive Nuclei per mirr of Liver Tissue From Fish Exposed to
6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Exposed Group
Day Mean Std. Dev. % RSD*
0 0 0 0.00
3 9 11 122.22
9 4 9 225.00
21 0 0 0.00
45 8 15 187.50
90 2 4 200.00
180 21 25 119.05
Control Group
Day Mean Std. Dev. % RSD
0 1 3 300.00
3 3 4 133.33
9 3 4 133.33
21 2 4 200.00
45 1 4 400.00
90 4 10 250.00
180 3 5 166.67
6.7 pM MNNG-Exposed Group
Day Mean Std. Dev. % RSD
0 1 4 400.00
3 2 3 150.00
9 6 10 166.67
21 1 2 200.00
45 1 2 200.00
90 5 10 200.00
180 73 63 86.30
* % RSD = (Std. Dev./Mean) 100 %
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Histogram 4.3. Immunohistochemical Detection of 
p53 (PAb 240) in the Liver of Fundulus grandis Fish 

















choice. The mode of fixation of Strek's tissue fixative is unknown, 
and it has not been recommended for use by any of the reagent 
manufacturers. The immunohistochemical detection of the p53 protein, 
using the anti-p53 monoclonal antibody PAb 240, in the nuclei of the 
epithelium from the gills, oral mucosa, and epidermis of Fundulus 
grandis was unexpected. It is believed that although wild type p53 
protein has a short half-life, mutations stabilize the protein 
allowing to be detected by immunohistochemistry (Fisher, Gillet et al. 
1994). It was thought that all immunohistochemically detected protein 
was mutant, as suggested by several reports (Smith, Yeleswarapu et al. 
1991; Lang, Maurer et al. 1992; Piug, Flejou et al. 1992; Porter, Gown 
et al. 1992; Goodwin and Grizzle 1994a; Goodwin and Grizzle 1994b).
126
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 4.4. Section of liver from a fish exposed to 6.7 pM MNNG 
at experimental day 180 stained for p53 PAb 240. Note the 
distinct nuclear deposition of the chromogen diaminobenzidine. 
(Nuclear Fast Red, 200X).
This may not necessarily be so. As discussed by Fisher (Fisher,
Gillet et al. 1994), increase in expression of the normal p53 protein
can occur in response to DNA damage (Kastan, Onyekwere et al. 1991;
Hall, McKee et al. 1993; Rasbridge, Gillet et al. 1993), and it has
been shown that excessive amounts of normal p53 may be detected by
immunohistochemistry (Hall, McKee et al. 1993; Rasbridge, Gillet et
al. 1993)). Why did the epithelial cells from the gills, oral mucosa,
and epidermis express apparently normal, wild type p53 protein in both
exposed and unexposed fish? Why not in the liver cells? It was
expected that positive p53 nuclear staining would be found in the
liver of Fundulus grandis by day 9 of the experiment. This was
demonstrated by Goodwin and Grizzle (Goodwin and Grizzle 1994a;
Goodwin and Grizzle 1994b), who used the monoclonal anti-p53 protein
PAb 4 21 (Oncogene, Calbiochem) on frozen liver sections from the spot
fish (Rivulus marmoratus ocellatus) exposed to diethylnitrosamine;
however, their description failed to describe whether the staining for
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p53 was nuclear or cytoplasmic. It is recognized that the tissue 
processing methods employed in this study were different from those 
used by these researchers (Goodwin and Grizzle 1994a; Goodwin and 
Grizzle 1994b), however.
Immunohistochemical Detection of p53 in the Liver of Fish
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
Sequential evaluation of hepatic immunohistochemical detection 
of the p53 protein in three groups of Fundulus grandis fish (control, 
MNNG-exposed, and 2-AF-exposed) revealed statistically significant 
differences in their levels of detection. The highest level of p53 
protein was detected in the MNNG exposed fish group on experimental 
day 180. Differences in the population means between this MNNG 
exposed fish group and that of the 2-AF exposed and control fish 
groups were highly significant (P = 0.0001).
The data obtained in this experiment suggest several points; 
first, that the anti-p53 PAb 240 monoclonal antibody protein may be a 
reliable marker of the p53 protein that occurs in Fundulus grandis 
fish; second, that MNNG-mediated cell injury induces changes in the 
DNA that may lead to increased levels of the p53 gene product due to 
either an increase in its expression/activity, or a decrease in its 
degradation; third, that there is a difference between the detected 
levels of p53 protein in the MNNG and 2-AF exposed groups, and in the 
MNNG exposed and control groups. No difference was found between the 
detected levels of p53 protein in the 2-AF exposed and control groups.
This finding of increased detection of p53 in the MNNG exposed 
group is consistent with previous findings discussed in chapters 2 and 
3, where evidence of suppression of apoptosis and increased net-cell 
proliferation in the liver of fish subjected to this compound was 
presented. These findings along with the increased occurrence of 
putative preneoplastic changes noted histologically (basophilic foci, 
megalocytosis, and karyomegaly) in this same MNNG exposed fish
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population, suggest that tumors with mutated p53 gene would develop, 
in time, in the livers of these fish. Based on these events, a 
general scheme on the possible mechanisms of MNNG carcinogenesis may 
be put together as shown in figure 4.5. Because similar histological 
changes were noted in the 2-AF exposed fish group in the absence of 
increased p53, it is expected that the neoplastic process which may 
occur as a result of exposure to this compound may not initially 
involve changes in the modulation of the p53 gene product, but that 
other mechanisms of carcinogenesis may be involved.
Stimuli by MNNG Biochemical Modifications 
and DNA Damage 
Adduct Formation
Increased Activity/ Levels 
of Mutant (?) p53, or 







Figure 4.5. General Scheme on the Possible Mechanisms of MNNG 
Carcinogenesis. Following stimuli by MNNG, a series of 
biochemical modifications or reactions occur that leads to 
direct DNA damage and adduct formation. This leads to 
increased accumulation of p53 protein as a result of a possible 
mutation of the p53 gene, an increase in its activity, or a 
decrease in its degradation. This leads to inhibition of 
apoptosis, loss of the cell cycle control, and a positive 
proliferation signal. Inhibition of apoptosis and positive 
signal for proliferation leads to genomic instability and 
subsequently, cancer (Legend: (+) = positive effect;
(-) = inhibitory effect).
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CHAPTER 5. CONCLUDING REMARKS
In this study, host response was measured through sequential 
immunohistochemical detection of apoptosis, PCNA, and p53 in livers of 
fish exposed to MNNG and 2-AF. Preservation of tissue morphology and 
application of mammalian methodologies for the immunohistochemical 
detection of apoptosis, PCNA-PC10, and p53-PAb240 were best preserved 
by buffered 10 % formalin solution.
The experiment suggests that the process of apoptosis in fish 
livers is suppressed as a result of exposure to MNNG. The lack of 
significant differences found in immunohistochemical detection of 
apoptosis between fish treated with MNNG and 2-AF suggests that the 
process of apoptosis is also affected in fish treated with 2-AF.
After chemically-mediated cell injury, fish liver cells respond 
by a significant increase in the level of PCNA expression that peaks 
by day 9 of the experiment regardless of the chemical compound used, 
MNNG or 2-AF. This resulted in hyperplastic changes that peaked on 
day 45 of the experiment in both MNNG and 2-AF treated groups. 
Therefore, the expression and detection of PCNA as an index of 
proliferation occurs much earlier than histologic evidence of 
proliferation (hyperplasia). However, it was also at day 45 of the 
experiment when the greatest detection of apoptosis was noted. These 
observations, taken together, may represent a balanced homeostatic 
response of the liver of Fundulus grandis as a result of exposure to 
MNNG or 2-AF. Therefore, concurrent use of a marker for cell death, 
or apoptosis, with one of proliferation greatly enhances the 
assessment of the effect of these compounds on liver cell 
proliferation and on the study of hepatic carcinogenesis. These 
experiments indicate that PCNA, PC-10, can be effectively used as an 
index of cell proliferation in liver and liver lesions found in 
Fundulus grandis fish.
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Sequential immunohistochemical detection of the p53 protein 
using anti-p53 PAb 240 monoclonal antibody protein revealed 
significant differences in their levels of detection. The highest 
level of p53 protein was detected in livers from fish exposed to MNNG 
on experimental day 180. Differences in the population means between 
this MNNG exposed fish group and that of the 2-AF exposed and control 
fish groups were highly significant.
The data obtained in this experiment suggest that the anti-p53 
PAb 240 monoclonal antibody protein may be used as a marker of the p53 
protein that occurs in Fundulus grandis fish; that MNNG-mediated cell 
injury induces changes (mutations) in the cellular DNA that may lead 
to increased levels of p53; and that there is a significant difference 
between the levels of p53 protein induced by the alkylating agent,
MNNG, and the polycyclic aromatic hydrocarbon, 2-AF, vs controls.
This finding of increased detection of p53 in the MNNG exposed 
group is consistent with previous findings discussed in chapters 2 and 
3, where evidence of suppression of apoptosis and increased net-cell 
proliferation in the liver of fish subjected to this compound was 
presented. These findings along with the increased occurrence of 
putative preneoplastic changes noted histologically (basophilic foci, 
megalocytosis, and karyomegaly) in this same MNNG exposed fish 
population, suggest that tumors with mutated p53 gene would develop, 
in time, in the livers of these fish. Because similar histological 
changes were noted in the 2-AF exposed fish group in the absence of 
increased p53, it is expected that the neoplastic process which may 
occur as a result of exposure to this compound may not initially 
involve changes in the modulation of the p53 gene product, but that 
other mechanisms of carcinogenesis may be involved.
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APPENDIX 2.A. GENERAL INFORMATION OF MNNG AND 2-AF
14466 13741
Name: Guanidine, N-methyl- Name: 9H-Fluorene-2-amine
N' -nitro-N-nitroso- MF: C13 Hn N
Synonym: MNNG CAS RN: 153-78-6
LF: CH3 N(N=0) C(=NH) NHNOj BEIL RN: 1945861
MF: C2 H5 N5 03 BEIL REF.: 4-12-00-03370
CAS RN: 70-25-7 HODOCNO.: 12711
BEIL RN: 1779490 MW: 181.24
BEIL REF.: 4-04-00-0338 6 MP [ °C]: 131.5 °C
MERK NO. : 6017 COLOR: pi or nd ( dil al)
HDOC NO. : 13370 SOL: H20 1; ETOH 3; ETH 3; ETC
MW: 147.09 3; CS2 3
SOL.: DMSO 3 MS: NIST 25380 181(100) 180( 6 6)
MS: NIST 52438 30(100) 43 152 (17) 182 (14) 90 ( 14) 153
(70) 72 (64) 42 (61) 55 (8 ) 165 (7) 76 ( 7) 151 (6) 163
(35) 57 (34) 44 (33) 15 (5)
(26) 56 (22) 29 (18) IR: mCOB 3800 2940 1610 1470
IR: SADG 21386 3380 3260 1390 1320 1280 1120 830 770
1620 1530 1460 1430 1370 740
1250 1220 1080 900 790 UV: SAD 54 286 MeOH
640 'H NMR: SAD 15452 3.5 3.7 6.6
'H NMR: SAD 9194 3.3 9.7 
DMSOde
(Lide And Milne 1994)
6.7 7.3 CDC13
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APPENDIX 2.B. REGRESSION ANALYSIS OF PEAK NUMBER 3 (MNNG)


















































Dep Var Predict Std Err Lower95% Upper95'4 Lower95% Upper95%
Obs AREA Value Predict Mean Mean Predict Predict Residual
1 754.6 61.987 582.5 926.7 502.1 1007.2 .
2 729.9 645.2 48.190 511.4 779.0 417.0 873.4 84.7319
3 494.9 535.7 36.179 435.3 636.2 325.3 746.1 -40.8455
4 371.7 426.3 28.324 347.6 504.9 225.4 627.2 -54.6230
5 271.4 316.8 28.324 238.2 395.5 115.9 517.7 -45.4504
6 201.9 207.4 36.179 106.9 307.8 -3.0171 417.8 -5.5078
7 159.6 97.9252 48.190 -35.8720 231.7 -130.3 326.1 61.6948
8 . -11.5273 61.987 -183.6 160.6 -264.1 241.0
9 -121.0 76.610 -333.7 91.7229 -402.8 160.8 .
10 -230.4 91.665 -484.9 24.0702 -545.0 84.1269 .
Sum of Residuals 0
Sum of Squared Residuals 17733.8362
Predicted Resid SS (Press) 59394.1395
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APPENDIX 2.C.I. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF APOPTOSIS (ISCDL) IN THE LIVER OF FUNDULUS GRANDIS
Class Level Information
Class Levels Values
GROUP 3 2-AF control mnng
DAY 7 0 3 9 21 45 90 180
Number of observations in data set = 210
Dependent Variable: ISCDL
Sum of Mean
Source DF Squares Square F Value Pr > F
Model 20 47221840.98 2361092.05 4.16 0.0001
Error 189 107188948.99 567137.30
Corrected Total 209 154410789.97
R-Square C.V. Root MSE ISCDL Mean
0.305820 51.09966 753.0852 1473.758
Source DF Type I SS Mean Square F Value Pr > F
GROUP 2 4516440.07 2258220.04 3.98 0.0202
DAY 6 33124284.70 5520714.12 9.73 0.0001
GROUP*DAY 12 9581116.21 798426.35 1.41 0.1651
Source DF Type III SS Mean Square F Value Pr > F
GROUP 2 4516440.07 2258220.04 3.98 0.0202
DAY 6 33124284.70 5520714.12 9.73 0.0001
GROUP*DAY 12 9581116.21 798426.35 1.41 0.1651
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APPENDIX 2.C.2. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF APOPTOSIS (ISCDL) IN THE LIVER OF FUNDULUS GRANDIS
Least Squares Means
GROUP ISCDL Std Err Pr > ITI LSMEAN
LSMEAN LSMEAN HO:LSMEAN=0 Number
2-AF 1476.32732 90.01090 0.0001 1
control 1652.07079 90.01090 0.0001 2
mnng 1292.87539 90.01090 0.0001 3
Pr > |T| HO: LSMEAN(i)-LSMEAN(j)
i/j 1 2 3
1 . 0.1690 0.1512
2 0.1690 . 0.0053
3 0.1512 0.0053
NOTE: To ensure overall protection level, only probabilities associated with 
pre-planned comparisons should be used.
DAY ISCDL Std Err Pr > |T| LSMEAN
LSMEAN LSMEAN HO:LSMEAN=0 Number
0 1332.05620 137.49391 0.0001 1
3 1550.65985 137.49391 0.0001 2
9 1385.16390 137.49391 0.0001 3
21 1079.60834 137.49391 0.0001 4
45 2383.88677 137.49391 0.0001 5
90 1394.63601 137.49391 0.0001 6
180 1190.29374 137.49391 0.0001 7
Pr > |T| HO: LSMEAN (i)=LSMEAN(j)
i/j 1 2 3 4 5 6 7
1 0.2623 0.7851 0.1958 0.,0001 0.7479 0.4669
2 0..2623 0.3958 0.0164 0.,0001 0.4233 0.0654
3 0..7851 0.3958 0.1178 0.,0001 0.9612 0.3175
4 0.,1958 0.0164 0.1178 0.,0001 0.1069 0.5699
5 0.,0001 0.0001 0.0001 0.0001 0.0001 0.0001
6 0.,7479 0.4233 0.9612 0.1069 0,,0001 . 0.2946
7 0.,4669 0.0654 0.3175 0.5699 0.,0001 0.2946 •
Least Squares Means
GROUP DAY ISCDL Std Err Pr > IT1 LSMEAN
LSMEAN LSMEAN HO: LSMEAN=0 Number
2-AF 0 1045.33845 238.14645 0.0001 1
2-AF 3 1807.79055 238.14645 0.0001 2
2-AF 9 1106.00256 238.14645 0.0001 3
2-AF 21 985.95147 238 . 14645 0.0001 4
2-AF 45 2598.65901 238.14645 0.0001 5
2-AF 90 1505.74713 238.14645 0.0001 6
2-AF 180 1284.80205 238.14645 0.0001 7
control 0 1881.22607 238.14645 0.0001 8
control 3 1359.51468 238.14645 0.0001 9
control 9 1547.25415 238.14645 0.0001 10
control 21 1360.79182 238.14645 0.0001 11
control 45 2296.29631 238 . 14645 0.0001 12
control 90 1498 .72286 238.14645 0.0001 13
control 180 1620.68964 238 . 14645 0.0001 14
mnng 0 1069.60409 238.14645 0.0001 15
mnng 3 1484.67432 238.14645 0.0001 16
mnng 9 1502.23499 238 . 14645 0.0001 17
mnng 21 892.08173 238.14645 0.0002 18
mnng 45 2256 .70500 238.14645 0.0001 19
mnng 90 1179.43805 238 .14645 0.0001 20
mnng 180 665.38953 238 . 14645 0.0057 21
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APPENDIX 2.C.3. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL























































































































































































































































































































14 15 16 17 18
0.0892 0.9426 0.1937 0.1765 0.6496
0.5792 0.0296 0.3386 0.3654 0.0072
0.1281 0.9141 0.2623 0.2409 0.5261
0.0610 0.8041 0.1403 0.1270 0.7808
0.0041 0.0001 0.0011 0.0013 0.0001
0.7333 0.1969 0.9502 0.9917 0.0700
0.3199 0.5236 0.5536 0.5193 0.2451
0.4401 0.0169 0.2405 0.2619 0.0037
0.4390 0.3904 0.7106 0.6722 0.1668
0.8276 0.1578 0.8528 0.8938 0.0532
0.4413 0.3884 0.7134 0.6750 0.1656
0.0463 0.0003 0.0169 0.0194 0.0001
0.7176 0.2042 0.9668 0.9917 0.0733
0.1034 0.6868 0.7254 0.0318
0.1034 . 0.2193 0.2005 0.5987
0.6868 0.2193 0.9585 0.0801
0.7254 0.2005 0.9585 . 0.0716
0.0318 0.5987 0.0801 0.0716
0.0605 0.0005 0.0230 0.0262 0.0001
0.1917 0.7447 0.3659 0.3391 0.3946





NOTE: To ensure overall protection 
level, only probabilities associated 
with pre-planned comparisons should be 
used.
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APPENDIX 3.A. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUNDULUS GRANDIS
Class Level Information 
Class Levels Values
GROUP 3 2-AF control mnng
DAY 7 0 3 9 21 45 90 180
Number of observations in data set = 210
Dependent Variable: PCNAL
Sum of Mean
Source DF Squares Square F Value Pr > F
Model 20 91711371.81 4585568.59 6.11 0.0001
Error 189 141832388.85 750435.92
Corrected Total 209 233543760.67
R-Square C.V. Root MSE PCNAL Mean
0.392695 49.56140 866.2770 1747.887
Source DF Type I SS Mean Square F Value Pr > F
GROUP 2 4066533.13 2033266.57 2.71 0.0692
DAY 6 64340161.04 10723360.17 14.29 0.0001
GROUP*DAY 12 23304677.64 1942056.47 2.59 0.0033
Source DF Type III SS Mean Square F Value Pr > F
GROUP 2 4066533.13 2033266.57 2.71 0.0692
DAY 6 64340161.04 10723360.17 14.29 0.0001
GROUP*DAY 12 23304677.64 1942056.47 2.59 0.0033
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APPENDIX 3.B. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUmXJLVS GRANDIS
GROUP
Least Squares Means 
PCNAL Std Err Pr > |TI LSMEAN













Pr > IT| HO: LSMEAN)i)=LSMEAN(j)
i/j 1 2 3
1 . 0.0215 0.3336
2 0.0215 . 0.1792
3 0.3336 0.1792
NOTE: To ensure overall protection level, only probabilities associated with 









0 1337 .59047 158.,15983 0.0001 1
3 2359 .30184 158..15983 0.0001 2
9 2574 .92550 158..15983 0.0001 3
21 2121 .54108 158..15983 0.0001 4
45 1565 .77267 158..15983 0.0001 5
90 1168 .79523 158..15983 0.0001 6
180 1107 .27969 158..15983 0.0001 7
Pr > |T| HO: LSMEAN)i)“LSMEAN(j)
i/j 1 2 3 4 5 6 71 0.0001 0.0001 0.0006 0..3090 0.4514 0.3045
2 0..0001 0.3363 0.2891 0.,0005 0.0001 0.0001
3 0..0001 0.3363 0.0441 0.,0001 0.0001 0.0001
4 0,.0006 0.2891 0.0441 0..0138 0.0001 0.0001
5 0..3090 0.0005 0.0001 0.0138 0.0775 0.0418
6 0,.4514 0.0001 0.0001 0.0001 0.,0775 . 0.7836
7 0..3045 0.0001 0.0001 0.0001 0.,0418 0.7836 •
Least Squares Means
GROUP DAY PCNAL Std Err Pr > |T| LSMEAN
LSMEAN LSMEAN HO:LSMEAN=0 Number
2-AF 0 1505.74713 273.94085 0.0001 1
2-AF 3 2784.16349 273.94085 0.0001 2
2-AF 9 2848.65902 273.94085 0.0001 3
2-AF 21 2414.43167 273.94085 0.0001 4
2-AF 45 1791.18773 273.94085 0.0001 5
2-AF 90 1077.90549 273.94085 0.0001 6
2-AF 180 936.14304 273.94085 0.0008 7
control 0 1636.65389 273.94085 0.0001 8
control 3 2412.51597 273.94085 0 .0001 9
control 9 1655.81098 273.94085 0.0001 10
control 21 2111.11110 273.94085 0.0001 11
control 45 1213.28226 273.94085 0.0001 12
control 90 895.27458 273.94085 0.0013 13
control 180 1058.10982 273.94085 0.0002 14
mnng 0 870.37038 273.94085 0.0017 15
mnng 3 1881.22606 273.94085 0.0001 16
mnng 9 3220.30650 273.94085 0.0001 17
mnng 21 1839.08046 273.94085 0 .0001 18
mnng 45 1692.84802 273.94085 0.0001 19
mnng 90 1533.20562 273.94085 0.0001 20
mnng 180 1327.58619 273.94085 0.0001 21
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APPENDIX 3.C. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUNDULUS GRANDIS
Pr > ITI HO: LSMEAN(i)“LSMEAN(j)
i,/j 1 2 3 4 5 6 7 8 9
1 . 0.0012 0.0007 0.0200 0.4622 0.2708 0.1431 0.7358 0.0203
2 0.0012 0.8680 0.3411 0.0112 0.0001 0.0001 0.0034 0.3386
3 0.0007 0.8680 0.2 638 0.0069 0.0001 0.0001 0.0020 0.2617
4 0.0200 0.3411 0.2638 . 0.1093 0.0007 0.0002 0.0461 0.9961
5 0.4622 0.0112 0.0069 0.1093 0.0672 0.0285 0.6904 0.1104
6 0.2708 0.0001 0.0001 0.0007 0.0672 0.7148 0.1509 0.0007
7 0.1431 0.0001 0.0001 0.0002 0.0285 0.7148 0.0722 0.0002
8 0.7358 0.0034 0.0020 0.0461 0.6904 0.1509 0.0722 0.0466
9 0.0203 0.3386 0.2617 0.9961 0.1104 0.0007 0.0002 0.0466
10 0.6989 0.0040 0.0024 0.0517 0.7271 0.1374 0.0648 0.9606 0.0523
11 0.1198 0.0840 0.0585 0.4346 0.4100 0.0083 0.0028 0.2222 0.4375
12 0.4512 0.0001 0.0001 0.0022 0.1374 0.7271 0.4753 0.2759 0.0023
13 0.1167 0.0001 0.0001 0.0001 0.0218 0.6379 0.9161 0.0572 0.0001
14 0.2494 0.0001 0.0001 0.0006 0.0600 0.9593 0.7532 0.1370 0.0006
15 0.1027 0.0001 0.0001 0.0001 0.0185 0.5928 0.8654 0.0494 0.0001
16 0.3337 0.0208 0.0134 0.1703 0.8165 0.0395 0.0156 0.5286 0.1719
17 0.0001 0.2617 0.3386 0.0389 0.0003 0.0001 0.0001 0.0001 0.0384
18 0.3907 0.0156 0.0099 0.1392 0.9017 0.0509 0.0208 0.6019 0.1405
19 0.6297 0.0054 0.0032 0.0641 0.7999 0.1141 0.0523 0.8848 0.0648
20 0.9436 0.0015 0.0008 0.0240 0.5063 0.2414 0.1250 0.7897 0.0244
21 0.6461 0.0002 0.0001 0.0056 0.2329 0.5200 0.3136 0.4260 0.0056





































































































































































































































































































NOTE: To ensure overall protection 
level, only probabilities associated 
with pre-planned comparisons should 
be used.
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APPENDIX 4.A. STATISTICAL DATA ANALYSIS FOR miUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRAND IS
General Linear Models Procedure 
Class Level Information
Class Levels Values
GROUP 3 2-AF control mnng
DAY 7 0 3 9 21 45 90 180
Number of observations in data set = 210
Dependent Variable: P53L
Sum of Mean
Source DF Squares Square F Value Pr > F
Model 20 50320.12300 2516.00615 9.75 0.0001
Error 189 48774.52515 258.06627
Corrected Total 209 99094.64816
R-Square C.V. Root MSE P53L Mean
0.507799 224.3292 16.06444 7.161102
Source DF Type I SS Mean Square F Value Pr > F
GROUP 2 3775.08691 1887.54345 7.31 0.0009
DAY 6 22816.63963 3802.77327 14.74 0.0001
GROUP*DAY 12 23728.39647 1977.36637 7.66 0.0001
Source DF Type III SS Mean Square F Value Pr > F
GROUP 2 3775.08691 1887.5434b 7.31 0.0009
DAY 6 22816.63963 3802.77327 14.74 0.0001
GROUP’DAY 12 23728.39647 1977.36637 7.66 0.0001
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APPENDIX 4.B. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRAHDIS
GROUP
Least Squares Means 
P53L Std Err Pr > |T| LSMEAN













Pr > IT| HO: LSMEAN(i)=LSMEAN(j)
i/j 1 2 3
1 . 0.1366 0.0225
2 0.1366 . 0.0002
3 0.0225 0.0002
NOTE: To ensure overall protection level, only probabilities associated with 





































Pr > | TI HO: LSMEAN (i) “LSMEAN (j )
i/j 1 2 3 4 5 6 7
1 0.3841 0.4126 1.0000 0.5388 0.4734 0.0001
2 0.3841 0.9591 0.3841 0.7978 0.8778 0.0001
3 0.4126 0.9591 0.4126 0.8376 0.9184 0.0001
4 1.0000 0.3841 0.4126 0.5388 0.4734 0.0001
5 0.5388 0.7978 0.8376 0.5388 0.9184 0.0001
6 0.4734 0.8778 0.9184 0.4734 0.9184 0.0001
7 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001
NOTE: To ensure overall protection level, only probabilities associated with 
pre-planned comparisons should be used.
Least Squares Means
GROUP DAY P53L Std Err Pr > |TI LSMEAN
LSMEAN LSMEAN HO:LSMEAN=0 Number
2-AF 0 - 0 .0 0 0 0 0 0 0 5.0800223 1 .0 0 0 0 1
2-AF 3 8.9399744 5.0800223 0.0801 2
2-AF 9 4.4699872 5.0800223 0.3800 3
2-AF 21 - 0 .0 0 0 0 0 0 0 5.0800223 1.0000 4
2-AF 45 8.3014048 5.0800223 0.1039 5
2-AF 90 2.5542784 5.0800223 0.6157 6
2-AF 180 20.7535120 5.0800223 0.0001 7
control 0 1.2771392 5.0800223 0.8018 8
control 3 2.5542784 5.0800223 0.6157 9
control 9 2.5542784 5.0800223 0.6157 10
control 21 1.9157088 5.0800223 0.7065 11
control 45 1.2771392 5.0800223 0.8018 12
control 90 3.8314176 5.0800223 0.4517 13
control 180 3.1928480 5.0800223 0.5304 14
mnng 0 1.2771392 5.0800223 0.8018 15
mnng 3 1.9157088 5.0800223 0.7065 16
mnng 9 5.7471264 5.0800223 0.2594 17
mnng 21 0.6385696 5.0800223 0.9001 18
mnng 45 0.6385696 5.0800223 0.9001 19
mnng 90 5.1085568 5.0800223 0.3159 20
mnng 180 73.4355040 5.0800223 0.0001 21
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APPENDIX 4.C. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRANDIS
Pr > ITI HO: LSMEAN(i)=LSMEAN (j)
i/j 1 2 3 4 5 6 7 8 9
1 , 0.2149 0.5346 1 .0 0 00 0.2493 0.7226 0.0043 0.8591 0.7226
2 0.2149 . 0.5346 0.2149 0.9293 0.3752 0.1018 0.2875 0.3752
3 0.5346 0.5346 0.5346 0.5944 0.7900 0.0245 0.6572 0.7900
4 1 . 0 0 0 0 0.2149 0!5346 , 0.2493 0.7226 0.0043 0.8591 0.7226
5 0.2493 0.9293 0.5944 0.2493 0.4247 0.0847 0.3295 0.4247
6 0.7226 0.3752 0.7900 0.7226 0.4247 . 0.0121 0.8591 1 . 0 0 0 0
7 0.0043 0.1018 0.0245 0.0043 0.0847 0.0121 0.0073 0.0121
8 0.8591 0.2875 0.6572 0.8591 0.3295 0.8591 0.0073 0.8591
9 0.7226 0.3752 0.7900 0.7226 0.4247 1 . 0 0 0 0 0.0121 0.8591 .
10 0.7226 0.3752 0.7900 0.7226 0.4247 1 . 0 0 0 0 0.0121 0.8591 1 . 0 0 0 0
11 0.7900 0.3295 0.7226 0.7900 0.3752 0.9293 0.0095 0.9293 0.9293
12 0.8591 0.2875 0.6572 0.8591 0.3295 0.8591 0.0073 1 . 0 0 0 0 0.8591
13 0.5944 0.4779 0.9293 0.5944 0.5346 0.8591 0.0195 0.7226 0.8591
14 0.6572 0.4247 0.8591 0.6572 0.4779 0.9293 0.0154 0.7900 0.9293
15 0.8591 0.2875 0.6572 0.8591 0.3295 0.8591 0.0073 1 . 0 0 0 0 0.8591
16 0.7900 0.3295 0.7226 0.7900 0.3752 0.9293 0.0095 0.9293 0.9293
17 0.4247 0.6572 0.8591 0.4247 0.7226 0.6572 0.0381 0.5346 0.6572
18 0.9293 0.2493 0.5944 0.9293 0.2875 0.7900 0.0056 0.9293 0.7900
19 0.9293 0.2493 0.5944 0.9293 0.2875 0.7900 0.0056 0.9293 0.7900
20 0.4779 0.5944 0.9293 0.4779 0.6572 0.7226 0.0307 0.5944 0.7226
21 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001
Pr > ITI HO: LSMEAN (i) =LSMEAN (j )
i/j 10 11 12 13 14 15 16 17 18
1 0.7226 0.7900 0.8591 0.5944 0.6572 0.8591 0.7900 0.4247 0.9293
2 0.3752 0.3295 0.2875 0.4779 0.4247 0.2875 0.3295 0.6572 0.2493
3 0.7900 0.7226 0.6572 0.9293 0.8591 0.6572 0.7226 0.8591 0.5944
4 0.7226 0.7900 0.8591 0.5944 0.6572 0.8591 0.7900 0.4247 0.9293
5 0.4247 0.3752 0.3295 0.5346 0.4779 0.3295 0.3752 0.7226 0.2875
6 1.0000 0.9293 0.8591 0.8591 0.9293 0.8591 0.9293 0.6572 0.7900
7 0.0121 0.0095 0.0073 0.0195 0.0154 0.0073 0.0095 0.0381 0.0056
8 0.8591 0.9293 1.0000 0.7226 0.7900 1.0000 0.9293 0.5346 0.9293
9 1.0000 0.9293 0.8591 0.8591 0.9293 0.8591 0.9293 0.6572 0.7900
10 . 0.9293 0.8591 0.8591 0.9293 0.8591 0.9293 0.6572 0.7900
11 0.9293 0.9293 0.7900 0.8591 0.9293 1.0000 0.5944 0.8591
12 0.8591 0.9293 0.7226 0.7900 1.0000 0.9293 0.5346 0.9293
13 0.8591 0.7900 0!7226 0.9293 0.7226 0.7900 0.7900 0.6572
14 0.9293 0.8591 0.7900 0.9293 0.7900 0.8591 0.7226 0.7226
15 0.8591 0.9293 1.0000 0.7226 0.7900 0.9293 0.5346 0.9293
16 0.9293 1.0000 0.9293 0.7900 0.8591 0.9293 0.5944 0.8591
17 0.6572 0.5944 0.5346 0.7900 0.7226 0.5346 0.5944 0.4779
18 0.7900 0.8591 0.9293 0.6572 0.7226 0.9293 0.8591 0.4779
19 0.7900 0.8591 0.9293 0.6572 0.7226 0.9293 0.8591 0.4779 1.0000
20 0.7226 0.6572 0.5944 0.8591 0.7900 0.5944 0.6572 0.9293 0.5346
21 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001
Pr > | T I HO: LSMEAN (i) =LSMEAN (j )
i/j 19 20 21 19 . 0.5346 0.0001
1 0.9293 0.4779 0.0001 20 0.5346 . 0.0001
2 0.2493 0.5944 0.0001 21 0.0001 0.0001
3 0.5944 0.9293 0.0001
4 0.9293 0.4779 0.0001 NOTE: To ensure overall
5 0.2875 0.6572 0.0001 protection level, only
6 0.7900 0.7226 0.0001 probabilities associated with
7 0.0056 0.0307 0.0001 pre-planned comparisons should
8 0.9293 0.5944 0.0001 be used.
9 0.7900 0.7226 0.0001
10 0.7900 0.7226 0.0001
11 0.8591 0.6572 0.0001
12 0.9293 0.5944 0.0001
13 0.6572 0.8591 0.0001
14 0.7226 0.7900 0.0001
15 0.9293 0.5944 0.0001
16 0.8591 0.6572 0.0001
17 0.4779 0.9293 0.0001
18 1.0000 0.5346 0.0001
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